Eric Hollander - Publications

Affiliations: 
Psychiatry Albert Einstein College of Medicine, New York, New York, United States 

399 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Fineberg NA, Stein DJ, Domschke K, Hollander E, Walitza S, Van Ameringen M, Dell'Osso B, Zohar J. An update from the WPA Section on Anxiety and Obsessive-Compulsive Disorders. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 23: 456-457. PMID 39279386 DOI: 10.1002/wps.21255  0.488
2023 Vismara M, Benatti B, Fineberg NA, Hollander E, Van Ameringen M, Menchon JM, Zohar J, Dell'Osso B. Lessons from a multicenter, international, large sample size analysis of patients with obsessive-compulsive disorders: an overview of the ICOCS Snapshot studies. Cns Spectrums. 1-9. PMID 37694338 DOI: 10.1017/S1092852923002432  0.359
2023 Taoulost S, Rasgon N, Ferretti CJ, Hollander E. The role of ketogenic therapy in developmental disorders. Journal of Psychiatric Research. 161: 307-309. PMID 36989905 DOI: 10.1016/j.jpsychires.2023.03.025  0.31
2022 Piccoli E, Hollander E. Editor's Commentary: Problematic Use of the internet in Autism Spectrum Disorder: A canary in the coal mine? Journal of Psychiatric Research. 155: 260-262. PMID 36116405 DOI: 10.1016/j.jpsychires.2022.09.002  0.346
2022 Fineberg NA, Menchón JM, Hall N, Dell'Osso B, Brand M, Potenza MN, Chamberlain SR, Cirnigliaro G, Lochner C, Billieux J, Demetrovics Z, Rumpf HJ, Müller A, Castro-Calvo J, Hollander E, et al. Advances in problematic usage of the internet research - A narrative review by experts from the European network for problematic usage of the internet. Comprehensive Psychiatry. 118: 152346. PMID 36029549 DOI: 10.1016/j.comppsych.2022.152346  0.6
2022 Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, Domschke K, Hollander E, Kasper S, Möller HJ, Eriksson E, Fineberg NA, Hättenschwiler J, Kaiya H, Karavaeva T, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-17. PMID 35900217 DOI: 10.1080/15622975.2022.2086296  0.418
2022 Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, Domschke K, Eriksson E, Fineberg NA, Hättenschwiler J, Hollander E, Kaiya H, Karavaeva T, Kasper S, Katzman M, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-39. PMID 35900161 DOI: 10.1080/15622975.2022.2086295  0.481
2022 Hollander E, Jacob S, Jou R, McNamara N, Sikich L, Tobe R, Smith J, Sanders K, Squassante L, Murtagh L, Gleissl T, Wandel C, Veenstra-VanderWeele J. Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 35793101 DOI: 10.1001/jamapsychiatry.2022.1717  0.31
2022 Simonoff E, Mowlem F, Pearson O, Anagnostou E, Donnelly C, Hollander E, King BH, McCracken JT, Scahill L, Sikich L, Pickles A. Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. Journal of Child and Adolescent Psychopharmacology. 32: 233-241. PMID 35501967 DOI: 10.1089/cap.2021.0137  0.329
2022 Benatti B, Girone N, Celebre L, Vismara M, Hollander E, Fineberg NA, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, van Ameringen M, Lochner C, Karamustafalioglu O, Hranov L, et al. The role of gender in a large international OCD sample: A Report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) Network. Comprehensive Psychiatry. 116: 152315. PMID 35483201 DOI: 10.1016/j.comppsych.2022.152315  0.66
2022 Taylor BP, Liu J, Mowrey W, Eule E, Bolognani F, Hollander E. The Montefiore-Einstein Rigidity Scale-Revised (MERS-R): Development, administration, reliability, and validity in child and adult Autism Spectrum Disorder (ASD). Journal of Psychiatric Research. 147: 142-147. PMID 35032947 DOI: 10.1016/j.jpsychires.2021.12.055  0.312
2021 Benatti B, Dell'Osso B, Shen H, Filippou-Frye M, Varias A, Sanchez C, Jo B, Hollander E, Fineberg NA, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, Van Ameringen M, et al. Prevalence and correlates of current suicide risk in an international sample of OCD adults: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) network and Obsessive Compulsive and Related Disorders Network (OCRN) of the European College of Neuropsychopharmacology. Journal of Psychiatric Research. 140: 357-363. PMID 34139458 DOI: 10.1016/j.jpsychires.2021.05.054  0.622
2020 Castle D, Beilharz F, Phillips KA, Brakoulias V, Drummond LM, Hollander E, Ioannidis K, Pallanti S, Chamberlain SR, Rossell SL, Veale D, Wilhelm S, Van Ameringen M, Dell'Osso B, Menchon JM, et al. Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology. International Clinical Psychopharmacology. PMID 33230025 DOI: 10.1097/YIC.0000000000000342  0.405
2020 Benatti B, Celebre L, Girone N, Priori A, Bruno A, Viganò C, Hollander E, Dell'Osso B. Clinical characteristics and comorbidity associated with female gender in obsessive-compulsive disorder. Journal of Psychiatric Research. 131: 209-214. PMID 32998082 DOI: 10.1016/j.jpsychires.2020.09.019  0.348
2020 Fineberg NA, Hollander E, Pallanti S, Walitza S, Grünblatt E, Dell'Osso BM, Albert U, Geller DA, Brakoulias V, Janardhan Reddy YC, Arumugham SS, Shavitt RG, Drummond L, Grancini B, De Carlo V, et al. Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders. International Clinical Psychopharmacology. PMID 32433254 DOI: 10.1097/Yic.0000000000000314  0.557
2020 Fineberg NA, Van Ameringen M, Drummond L, Hollander E, Stein DJ, Geller D, Walitza S, Pallanti S, Pellegrini L, Zohar J, Rodriguez CI, Menchon JM, Morgado P, Mpavaenda D, Fontenelle LF, et al. How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology. Comprehensive Psychiatry. 100: 152174. PMID 32388123 DOI: 10.1016/J.Comppsych.2020.152174  0.692
2020 Del Valle Rubido M, Hollander E, McCracken JT, Shic F, Noeldeke J, Boak L, Khwaja O, Sadikhov S, Fontoura P, Umbricht D. Exploring Social Biomarkers in High-Functioning Adults with Autism and Asperger's Versus Healthy Controls: A Cross-Sectional Analysis. Journal of Autism and Developmental Disorders. PMID 32279223 DOI: 10.1007/S10803-020-04493-5  0.373
2019 Burchi E, Makris N, Lee MR, Pallanti S, Hollander E. Compulsivity in Alcohol Use Disorder and Obsessive Compulsive Disorder: Implications for Neuromodulation. Frontiers in Behavioral Neuroscience. 13: 70. PMID 31139059 DOI: 10.3389/Fnbeh.2019.00070  0.483
2019 Dell'Osso B, Vismara M, Benatti B, Cirnigliaro G, Grancini B, Fineberg NA, Van Ameringen M, Hollander E, Stein DJ, Menchon JM, Rodriguez CI, Nicolini H, Lanzagorta N, Pallanti S, Grassi G, et al. Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Cns Spectrums. 1-7. PMID 31131775 DOI: 10.1017/S1092852919001068  0.717
2019 Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger DM, Daskalakis J, Ward H, Lapidus K, Goodman W, Casuto L, Feifel D, Barnea-Ygael N, Roth Y, Zangen A, Zohar J. Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial. The American Journal of Psychiatry. appiajp201918101180. PMID 31109199 DOI: 10.1176/Appi.Ajp.2019.18101180  0.373
2019 Dong N, Nezgovorova V, Hong K, Hollander E. Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments. Expert Opinion On Pharmacotherapy. 1-9. PMID 31038370 DOI: 10.1080/14656566.2019.1610385  0.436
2019 Fineberg NA, Dell'Osso B, Albert U, Maina G, Geller D, Carmi L, Sireau N, Walitza S, Grassi G, Pallanti S, Hollander E, Brakoulias V, Menchon JM, Marazziti D, Ioannidis K, et al. Early intervention for obsessive compulsive disorder: An expert consensus statement. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30773387 DOI: 10.1016/J.Euroneuro.2019.02.002  0.549
2019 Hollander E, Jean Ferretti C. Assessment and Treatment of Autism Spectrum Disorder Psychiatric News. 54. DOI: 10.1176/appi.pn.2019.1a21  0.386
2018 Fineberg NA, Demetrovics Z, Stein DJ, Ioannidis K, Potenza MN, Grünblatt E, Brand M, Billieux J, Carmi L, King DL, Grant JE, Yücel M, Dell'Osso B, Rumpf HJ, Hall N, ... Hollander E, et al. Manifesto for a European research network into Problematic Usage of the Internet. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 28: 1232-1246. PMID 30509450 DOI: 10.1016/J.Euroneuro.2018.08.004  0.453
2018 Del Valle Rubido M, McCracken JT, Hollander E, Shic F, Noeldeke J, Boak L, Khwaja O, Sadikhov S, Fontoura P, Umbricht D. In Search of Biomarkers for Autism Spectrum Disorder. Autism Research : Official Journal of the International Society For Autism Research. PMID 30324656 DOI: 10.1002/Aur.2026  0.378
2018 Hollander E, Uzunova G, Taylor BP, Noone R, Racine E, Doernberg E, Freeman K, Ferretti CJ. Randomized Crossover Feasibility Trial of Helminthic Trichuris Suis Ova vs. Placebo for Repetitive Behaviors in Adult Autism Spectrum Disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-25. PMID 30230399 DOI: 10.1080/15622975.2018.1523561  0.45
2018 Burchi E, Hollander E, Pallanti S. From Treatment Response to Recovery - a Realistic Goal in OCD. The International Journal of Neuropsychopharmacology. PMID 30184141 DOI: 10.1093/Ijnp/Pyy079  0.444
2018 Hong K, Nezgovorova V, Uzunova G, Schlussel D, Hollander E. Pharmacological Treatment Of Body Dysmorphic Disorder. Current Neuropharmacology. PMID 29701157 DOI: 10.2174/1570159X16666180426153940  0.525
2018 Hong K, Nezgovorova V, Hollander E. New perspectives in the treatment of body dysmorphic disorder. F1000research. 7: 361. PMID 29636904 DOI: 10.12688/F1000Research.13700.1  0.452
2018 Benatti B, Dell’Osso B, Rodriguez CI, Arici C, Palazzo C, Altamura AC, Hollander E, Fineberg N, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, Ameringen MV, Lochner C, et al. Exploring Sociodemographic And Clinical Correlates Of Older Adults With Obsessive-Compulsive Disorder: A Report From The International College Of Obsessive-Compulsive Disorders (Icocs) European Neuropsychopharmacology. 28: 765-766. DOI: 10.1016/J.Euroneuro.2017.10.007  0.646
2018 Rahman A, Freedman R, Hollander E. S59. Alpha-7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator Galantamine in Autism Spectrum Disorder Biological Psychiatry. 83: S369-S370. DOI: 10.1016/J.Biopsych.2018.02.950  0.343
2017 Mitelman SA, Buchsbaum MS, Young DS, Haznedar MM, Hollander E, Shihabuddin L, Hazlett EA, Bralet MC. Increased white matter metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging and Behavior. PMID 29168086 DOI: 10.1007/S11682-017-9785-9  0.336
2017 Kabasakalian A, Ferretti CJ, Hollander E. Oxytocin and Prader-Willi Syndrome. Current Topics in Behavioral Neurosciences. PMID 28956320 DOI: 10.1007/7854_2017_28  0.391
2017 Dell'Osso B, Benatti B, Rodriguez CI, Arici C, Palazzo C, Altamura AC, Hollander E, Fineberg N, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, Van Ameringen M, Lochner C, et al. Obsessive-compulsive disorder in the elderly: A report from the International College of Obsessive-Compulsive Disorders (ICOCS). European Psychiatry : the Journal of the Association of European Psychiatrists. 45: 36-40. PMID 28728093 DOI: 10.1016/J.Eurpsy.2017.06.008  0.693
2017 Chiarello F, Spitoni S, Hollander E, Matucci Cerinic M, Pallanti S. An expert opinion on PANDAS/PANS: highlights and controversies. International Journal of Psychiatry in Clinical Practice. 21: 91-98. PMID 28498087 DOI: 10.1080/13651501.2017.1285941  0.461
2017 Mitelman SA, Bralet MC, Mehmet Haznedar M, Hollander E, Shihabuddin L, Hazlett EA, Buchsbaum MS. Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging and Behavior. PMID 28425060 DOI: 10.1007/S11682-017-9721-Z  0.307
2017 Vasudeva SB, Hollander E. Body Dysmorphic Disorder in Patients With Autism Spectrum Disorder: A Reflection of Increased Local Processing and Self-Focus. The American Journal of Psychiatry. 174: 313-316. PMID 28366095 DOI: 10.1176/Appi.Ajp.2016.16050559  0.473
2017 Dell'Osso B, Benatti B, Arici C, Palazzo C, Altamura AC, Hollander E, Fineberg N, Stein DJ, Nicolini H, Lanzagorta N, Marazziti D, Pallanti S, van Ameringen M, Lochner C, Karamustafalioglu O, et al. Prevalence of suicide attempt and clinical characteristics of suicide attempters with obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Cns Spectrums. 1-8. PMID 28300008 DOI: 10.1017/S1092852917000177  0.666
2017 Hollander E, Uzunova G. Are there new advances in the pharmacotherapy of autism spectrum disorders? World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 16: 101-102. PMID 28127936 DOI: 10.1002/Wps.20398  0.478
2017 Dell'Osso B, Benatti B, Hollander E, Altamura AC. Clinical features associated with increased severity of illness in tertiary clinic referred patients with obsessive compulsive disorder. International Journal of Psychiatry in Clinical Practice. 21: 131-136. PMID 27809644 DOI: 10.1080/13651501.2016.1249891  0.442
2017 Dell׳Osso B, Benatti B, Nicolini H, Lanzagorta N, Palazzo MC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Ameringen MV, Lochner C, Hranov G, Karamustafalioglu O, Hranov L, et al. Childhood, Adolescent And Adult Age At Onset And Related Clinical Correlates In Obsessive-Compulsive Disorder: A Report From The International College Of Obsessive-Compulsive Disorders (Icocs) European Neuropsychopharmacology. 27: 610-611. DOI: 10.1016/J.Euroneuro.2016.07.013  0.642
2017 Hollander E, Pallanti S, McElroy S, Fineberg N. 44. Experimental Therapeutics, Mechanism of Action, and Striatal Gradients in Compulsive and Impulsive Disorders Biological Psychiatry. 81: S19. DOI: 10.1016/J.Biopsych.2017.02.055  0.446
2016 Umbricht D, Del Valle Rubido M, Hollander E, McCracken JT, Shic F, Scahill L, Noeldeke J, Boak L, Khwaja O, Squassante L, Grundschober C, Kletzl H, Fontoura P. A Single Dose, Randomized, Controlled Proof-of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27711048 DOI: 10.1038/Npp.2016.232  0.386
2016 DellʼOsso B, Benatti B, Altamura AC, Hollander E. Prevalence of Selective Serotonin Reuptake Inhibitor-Related Apathy in Patients With Obsessive Compulsive Disorder. Journal of Clinical Psychopharmacology. 36: 725-726. PMID 27631577 DOI: 10.1097/Jcp.0000000000000572  0.454
2016 Hollander E, Hong K. Relapse Prevention and the Need for Ongoing Pharmacological Treatment in Body Dysmorphic Disorder. The American Journal of Psychiatry. 173: 857-9. PMID 27581691 DOI: 10.1176/Appi.Ajp.2016.16050624  0.455
2016 Dell'Osso B, Benatti B, Hollander E, Fineberg N, Stein DJ, Lochner C, Nicolini H, Lanzagorta N, Palazzo C, Altamura AC, Marazziti D, Pallanti S, Van Ameringen M, Karamustafalioglu O, Drummond LM, et al. Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). International Journal of Psychiatry in Clinical Practice. 1-8. PMID 27433835 DOI: 10.1080/13651501.2016.1207087  0.682
2016 Doernberg E, Hollander E. Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11. Cns Spectrums. 21: 295-9. PMID 27364515 DOI: 10.1017/S1092852916000262  0.484
2016 Menchón JM, van Ameringen M, Dell'Osso B, Denys D, Figee M, Grant JE, Hollander E, Marazziti D, Nicolini H, Pallanti S, Ruck C, Shavitt R, Stein DJ, Andersson E, Bipeta R, et al. Standards of care for obsessive-compulsive disorder centres. International Journal of Psychiatry in Clinical Practice. 20: 204-208. PMID 27359333 DOI: 10.1080/13651501.2016.1197275  0.688
2016 Hollander E, Doernberg E, Shavitt R, Waterman RJ, Soreni N, Veltman DJ, Sahakian BJ, Fineberg NA. The cost and impact of compulsivity: A research perspective. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 26: 800-9. PMID 27235690 DOI: 10.1016/J.Euroneuro.2016.02.006  0.502
2016 Pallanti S, Marras A, Salerno L, Makris N, Hollander E. Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial. Journal of Psychopharmacology (Oxford, England). PMID 26843373 DOI: 10.1177/0269881116628427  0.39
2016 Uzunova G, Pallanti S, Hollander E. Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 17: 174-86. PMID 26469219 DOI: 10.3109/15622975.2015.1085597  0.432
2016 Del Valle Rubido M, Hollander E, McCracken J, Shic F, Noeldeke J, Boak L, Khwaja O, Sadikhov S, Fontoura P, Umbricht D. A multi-center, observational study to explore the relationship between exploratory biomarkers and functional dimensions in adults with autistic spectrum disorders European Neuropsychopharmacology. 26: S193. DOI: 10.1016/S0924-977X(16)31031-8  0.405
2016 Hollander E, Ferretti CJ, Taylor BP, Noone R, Kirsch J, Racine E. TRICHURIS SUIS OVA (TSO) AS AN IMMUNE-INFLAMMATORY TREATMENT FOR REPETITIVE BEHAVIORS IN ASD European Neuropsychopharmacology. 26: 891. DOI: 10.1016/J.Euroneuro.2015.06.023  0.388
2016 Ferretti CJ, Taylor BP, Noone R, Racine E, Kirsch J, Hollander E. HYPERTHERMIA AND THE IMPROVEMENT OF ASD SYMPTOMS European Neuropsychopharmacology. 26: 890-891. DOI: 10.1016/J.Euroneuro.2015.06.022  0.335
2016 Hollander E, Taylor BP, Racine E, Ferretti CJ, Noone R. IMPULSIVITY AND COMPULSIVITY: TRANSLATIONAL APPROACHES TO COMPULSIVITY IN AUTISM SPECTRUM DISORDERS European Neuropsychopharmacology. 26: 889-890. DOI: 10.1016/J.Euroneuro.2015.06.021  0.331
2015 Grant JE, Fineberg N, van Ameringen M, Cath D, Visser H, Carmi L, Pallanti S, Hollander E, van Balkom AJ. New treatment models for compulsive disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26621260 DOI: 10.1016/J.Euroneuro.2015.11.008  0.519
2015 Dell'Osso B, Nicolini H, Lanzagorta N, Benatti B, Spagnolin G, Palazzo MC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Van Ameringen M, Lochner C, Hranov G, Karamustafalioglu O, et al. Cigarette smoking in patients with obsessive compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). Cns Spectrums. 1-5. PMID 26349811 DOI: 10.1017/S1092852915000565  0.66
2015 Simberlund J, Ferretti CJ, Hollander E. Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-8. PMID 26230216 DOI: 10.3109/15622975.2015.1067372  0.405
2015 Bartz JA, Lydon JE, Kolevzon A, Zaki J, Hollander E, Ludwig N, Bolger N. Differential Effects of Oxytocin on Agency and Communion for Anxiously and Avoidantly Attached Individuals. Psychological Science. 26: 1177-86. PMID 26122122 DOI: 10.1177/0956797615580279  0.715
2015 Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, Tendler A, Daskalakis ZJ, Winston JL, Dannon P, Hafez HM, Reti IM, Morales OG, Schlaepfer TE, Hollander E, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 64-73. PMID 25655160 DOI: 10.1002/Wps.20199  0.332
2015 Seibell PJ, Hamblin RJ, Hollander E. Obsessive-Compulsive Disorder: Overview and Standard Treatment Strategies Psychiatric Annals. 45: 297-302. DOI: 10.3928/00485713-20150602-04  0.495
2015 Bartz JA, Lydon JE, Kolevzon A, Zaki J, Hollander E, Ludwig N, Bolger N. Differential Effects of Oxytocin on Agency and Communion for Anxiously and Avoidantly Attached Individuals Psychological Science. 26: 1177-1186. DOI: 10.1177/0956797615580279  0.685
2015 Del Valle Rubido M, Umbricht D, Shic F, McCracken J, Scahill L, Khwaja O, Squassante L, Boak L, Bolognani F, Fontoura P, Wall C, Jou R, Loomis R, Lyons M, Gavaletz A, ... ... Hollander E, et al. P.7.d.011 Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorder European Neuropsychopharmacology. 25: S646-S647. DOI: 10.1016/S0924-977X(15)30917-2  0.348
2014 Seibell PJ, Hollander E. Management of obsessive-compulsive disorder. F1000prime Reports. 6: 68. PMID 25165567 DOI: 10.12703/P6-68  0.492
2014 Chaim CH, Nazar BP, Hollander E, Lessa JL. Pathological gambling treated with lithium: the role of assessing temperament. Addictive Behaviors. 39: 1911-3. PMID 25163751 DOI: 10.1016/J.Addbeh.2014.05.016  0.463
2014 Lochner C, Fineberg NA, Zohar J, van Ameringen M, Juven-Wetzler A, Altamura AC, Cuzen NL, Hollander E, Denys D, Nicolini H, Dell'Osso B, Pallanti S, Stein DJ. Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Comprehensive Psychiatry. 55: 1513-9. PMID 25011690 DOI: 10.1016/J.Comppsych.2014.05.020  0.722
2014 Hollander E. Obsessive-compulsive disorder and spectrum across the life span. International Journal of Psychiatry in Clinical Practice. 9: 79-86. PMID 24930787 DOI: 10.1080/13651500510018347  0.529
2014 Hollander E. Anxiety and OC spectrum disorders over life cycle. International Journal of Psychiatry in Clinical Practice. 5-10. PMID 24926866 DOI: 10.1080/13651500701388468  0.532
2014 Pallanti S, Grassi G, Antonini S, Quercioli L, Salvadori E, Hollander E. rTMS in resistant mixed states: an exploratory study. Journal of Affective Disorders. 157: 66-71. PMID 24581830 DOI: 10.1016/J.Jad.2013.12.024  0.358
2014 Uzunova G, Hollander E, Shepherd J. The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome. Current Neuropharmacology. 12: 71-98. PMID 24533017 DOI: 10.2174/1570159X113116660046  0.395
2014 Van Ameringen M, Simpson W, Patterson B, Dell'Osso B, Fineberg N, Hollander E, Hranov L, Hranov G, Lochner C, Karamustafalioglu O, Marazziti D, Menchon JM, Nicolini H, Pallanti S, Stein DJ, et al. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers. Journal of Psychopharmacology (Oxford, England). 28: 596-602. PMID 24429223 DOI: 10.1177/0269881113517955  0.671
2014 Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E. Ondansetron augmentation in patients with obsessive-compulsive disorder who are inadequate responders to serotonin reuptake inhibitors: improvement with treatment and worsening following discontinuation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 375-80. PMID 24406025 DOI: 10.1016/J.Euroneuro.2013.12.003  0.393
2014 Hollander E. Compulsivity and impulsivity-personal reflections: why now and why here? Cns Spectrums. 19: 6-7. PMID 24284261 DOI: 10.1017/S1092852913000886  0.34
2014 Berlin GS, Hollander E. Compulsivity, impulsivity, and the DSM-5 process Cns Spectrums. 19: 62-68. PMID 24229702 DOI: 10.1017/S1092852913000722  0.371
2014 Pallanti S, Hollander E. Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity. Cns Spectrums. 19: 50-61. PMID 24176028 DOI: 10.1017/S1092852913000618  0.466
2014 Benatti B, Dell'Osso B, Arici C, Hollander E, Altamura AC. Characterizing impulsivity profile in patients with obsessive-compulsive disorder. International Journal of Psychiatry in Clinical Practice. 18: 156-60. PMID 24151922 DOI: 10.3109/13651501.2013.855792  0.456
2014 Hirota T, Veenstra-Vanderweele J, Hollander E, Kishi T. Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis. Journal of Autism and Developmental Disorders. 44: 948-57. PMID 24077782 DOI: 10.1007/S10803-013-1952-2  0.391
2014 Hollander E, Ferretti C, Taylor B, Noone R, Racine E. P.7.d.006 Trichuris Suis Ova (TSO) as an immune-inflammatory treatment for repetitive behaviors in autism spectrum disorders (ASD) European Neuropsychopharmacology. 24: S723. DOI: 10.1016/S0924-977X(14)71165-4  0.414
2014 Racine E, Kahn T, Hollander E. Compulsive Buying Disorder Behavioral Addictions: Criteria, Evidence, and Treatment. 285-315. DOI: 10.1016/B978-0-12-407724-9.00012-4  0.42
2013 King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. Jama Pediatrics. 167: 1045-52. PMID 24061784 DOI: 10.1001/Jamapediatrics.2013.2698  0.347
2013 Dell'Osso B, Benatti B, Buoli M, Altamura AC, Marazziti D, Hollander E, Fineberg N, Stein DJ, Pallanti S, Nicolini H, Van Ameringen M, Lochner C, Hranov G, Karamustafalioglu O, Hranov L, et al. The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 865-71. PMID 23791074 DOI: 10.1016/J.Euroneuro.2013.05.004  0.651
2013 Doyle-Thomas KA, Duerden EG, Taylor MJ, Lerch JP, Soorya LV, Wang AT, Fan J, Hollander E, Anagnostou E. Effects of age and symptomatology on cortical thickness in autism spectrum disorders. Research in Autism Spectrum Disorders. 7: 141-150. PMID 23678367 DOI: 10.1016/J.Rasd.2012.08.004  0.358
2013 Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 43: 2341-52. PMID 23400347 DOI: 10.1007/S10803-013-1775-1  0.382
2013 Berlin HA, Braun A, Simeon D, Koran LM, Potenza MN, McElroy SL, Fong T, Pallanti S, Hollander E. A double-blind, placebo-controlled trial of topiramate for pathological gambling. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 14: 121-8. PMID 21486110 DOI: 10.3109/15622975.2011.560964  0.387
2012 Anagnostou E, Soorya L, Chaplin W, Bartz J, Halpern D, Wasserman S, Wang AT, Pepa L, Tanel N, Kushki A, Hollander E. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Molecular Autism. 3: 16. PMID 23216716 DOI: 10.1186/2040-2392-3-16  0.678
2012 Fan J, Bernardi S, Van Dam NT, Anagnostou E, Gu X, Martin L, Park Y, Liu X, Kolevzon A, Soorya L, Grodberg D, Hollander E, Hof PR. Functional deficits of the attentional networks in autism. Brain and Behavior. 2: 647-60. PMID 23139910 DOI: 10.1002/Brb3.90  0.328
2012 Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. International Journal of Psychiatry in Clinical Practice. 16: 77-84. PMID 22540422 DOI: 10.3109/13651501.2012.667114  0.477
2012 Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. The American Journal of Psychiatry. 169: 292-9. PMID 22193531 DOI: 10.1176/Appi.Ajp.2011.10050764  0.396
2012 Marazziti D, Rossi L, Baroni S, Consoli G, Hollander E, Catena-Dell'Osso M. Novel treatment options of binge eating disorder. Current Medicinal Chemistry. 18: 5159-64. PMID 22050761 DOI: 10.2174/092986711797636045  0.444
2012 Allen A, King A, Hollander E. Obsessive-compulsive spectrum disorders. Dialogues in Clinical Neuroscience. 5: 259-71. PMID 22033547  0.443
2012 Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, et al. Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 42: 432-40. PMID 21667200 DOI: 10.1007/S10803-011-1251-8  0.417
2012 Hollander E. A unique look at women and mood disorders. Cns Spectrums. 4: 9. PMID 18438306 DOI: 10.1017/S109285290001227X  0.408
2012 Hollander E. New research in impulsive and compulsive disorders. Cns Spectrums. 4: 9. PMID 18311102 DOI: 10.1017/S109285290000674X  0.462
2012 Hollander E, Mucci RT, Mucci CB. The obsessive compulsive spectrum: a survey of 800 practitioners. Cns Spectrums. 5: 61-4. PMID 18192941 DOI: 10.1017/S1092852900007550  0.497
2012 Antar LN, Ferretti CJ, Hollander E. Immune Response and Inflammation in Autism Spectrum Disorder Psychiatric Annals. 42: 342-346. DOI: 10.3928/00485713-20120906-08  0.421
2012 Antar LN, Hollander E. This Issue: Case Challenges in Autism Spectrum Disorder Psychiatric Annals. 42: 284-285. DOI: 10.3928/00485713-20120806-03  0.45
2012 Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, Möller HJ. Erratum: Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care (International Journal of Psychiatry in Clinical Practice (2012) 16 (77-84)) International Journal of Psychiatry in Clinical Practice. 16. DOI: 10.3109/13651501.2012.700008  0.492
2011 Ameis SH, Fan J, Rockel C, Voineskos AN, Lobaugh NJ, Soorya L, Wang AT, Hollander E, Anagnostou E. Impaired structural connectivity of socio-emotional circuits in autism spectrum disorders: a diffusion tensor imaging study. Plos One. 6: e28044. PMID 22132206 DOI: 10.1371/Journal.Pone.0028044  0.307
2011 Girgis RR, Slifstein M, Xu X, Frankle WG, Anagnostou E, Wasserman S, Pepa L, Kolevzon A, Abi-Dargham A, Laruelle M, Hollander E. The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB. Psychiatry Research. 194: 230-4. PMID 22079057 DOI: 10.1016/J.Pscychresns.2011.04.007  0.379
2011 Simeon D, Bartz J, Hamilton H, Crystal S, Braun A, Ketay S, Hollander E. Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study. Psychoneuroendocrinology. 36: 1418-21. PMID 21546164 DOI: 10.1016/J.Psyneuen.2011.03.013  0.654
2011 Fineberg NA, Chamberlain SR, Hollander E, Boulougouris V, Robbins TW. Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment. British Journal of Pharmacology. 164: 1044-61. PMID 21486280 DOI: 10.1111/J.1476-5381.2011.01422.X  0.41
2011 Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E, Hof PR, Fan J. In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Research. 1380: 198-205. PMID 21185269 DOI: 10.1016/J.Brainres.2010.12.057  0.33
2011 Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A, Vicens V, Hollander E. Oxytocin can hinder trust and cooperation in borderline personality disorder. Social Cognitive and Affective Neuroscience. 6: 556-63. PMID 21115541 DOI: 10.1093/Scan/Nsq085  0.701
2011 Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 72: 716-21. PMID 20816027 DOI: 10.4088/Jcp.09M05266Gre  0.394
2011 Morgenstern J, Muench F, O'Leary A, Wainberg M, Parsons JT, Hollander E, Blain L, Irwin T. Non-paraphilic compulsive sexual behavior and psychiatric co-morbidities in gay and bisexual men Sexual Addiction and Compulsivity. 18: 114-134. DOI: 10.1080/10720162.2011.593420  0.331
2010 Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. The British Journal of Psychiatry : the Journal of Mental Science. 197: 330-1. PMID 20884959 DOI: 10.1192/Bjp.Bp.110.078105  0.33
2010 Bartz JA, Zaki J, Bolger N, Hollander E, Ludwig NN, Kolevzon A, Ochsner KN. Oxytocin selectively improves empathic accuracy. Psychological Science. 21: 1426-8. PMID 20855907 DOI: 10.1177/0956797610383439  0.592
2010 Green JJ, Hollander E. Autism and oxytocin: new developments in translational approaches to therapeutics. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 7: 250-7. PMID 20643377 DOI: 10.1016/J.Nurt.2010.05.006  0.394
2010 Pallanti S, Haznedar MM, Hollander E, Licalzi EM, Bernardi S, Newmark R, Buchsbaum MS. Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study. Neuropsychobiology. 62: 132-8. PMID 20588072 DOI: 10.1159/000317286  0.376
2010 Koran LM, Bromberg D, Hornfeldt CS, Shepski JC, Wang S, Hollander E. Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder. Comprehensive Psychiatry. 51: 373-9. PMID 20579510 DOI: 10.1016/J.Comppsych.2009.10.001  0.387
2010 Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, Fineberg N, Mataix-Cols D, Ferrão YA, Saxena S, Wilhelm S, Kelly MM, Clark LA, Pinto A, Bienvenu OJ, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depression and Anxiety. 27: 528-55. PMID 20533367 DOI: 10.1002/Da.20705  0.51
2010 Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. The Journal of Clinical Psychiatry. 71: 784-92. PMID 20492845 DOI: 10.4088/Jcp.09M05911Blu  0.502
2010 Bernardi S, Cortese S, Solanto M, Hollander E, Pallanti S. Bipolar disorder and comorbid attention deficit hyperactivity disorder. A distinct clinical phenotype? Clinical characteristics and temperamental traits. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 656-66. PMID 20353313 DOI: 10.3109/15622971003653238  0.404
2010 Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL, Goodman WK, Phillips KA, Stein DJ. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depression and Anxiety. 27: 507-27. PMID 20217853 DOI: 10.1002/Da.20669  0.456
2010 Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, Feirsen N, Pepa L, Anagnostou E. Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 990-8. PMID 20010551 DOI: 10.1038/Npp.2009.202  0.425
2010 Dell'Osso B, Buoli M, Hollander E, Altamura AC. Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 59-65. PMID 20001657 DOI: 10.3109/15622970903418544  0.516
2010 Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 591-604. PMID 19940844 DOI: 10.1038/Npp.2009.185  0.418
2010 Pallanti S, Bernardi S, Allen A, Hollander E. Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan. Journal of Psychopharmacology (Oxford, England). 24: 1802-9. PMID 19825906 DOI: 10.1177/0269881109106907  0.317
2010 Fineberg N, Stein D, Legault M, Marteau F, Hollander E. P.4.a.001 Quality of life outcomes in obsessive-compulsive disorder: relationship to treatment response and symptom relapse European Neuropsychopharmacology. 20: S520-S521. DOI: 10.1016/S0924-977X(10)70778-1  0.489
2009 Hankin CS, Koran LM, Bronstone A, Black DW, Sheehan DV, Hollander E, Dunn JD, Culpepper L, Knispel J, Dougherty DD, Wang Z. Adequacy of pharmacotherapy among medicaid-enrolled patients newly diagnosed with obsessive-compulsive disorder. Cns Spectrums. 14: 695-703. PMID 20394177 DOI: 10.1017/S1092852900023956  0.491
2009 Pallanti S, Bernardi S, Antonini S, Singh N, Hollander E. Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study. Cns Drugs. 23: 1047-55. PMID 19958042 DOI: 10.2165/11530240-000000000-00000  0.371
2009 Hollander E, Wang AT, Braun A, Marsh L. Neurological considerations: autism and Parkinson's disease. Psychiatry Research. 170: 43-51. PMID 19815296 DOI: 10.1016/J.Psychres.2008.07.014  0.451
2009 Hollander E, Kim S, Braun A, Simeon D, Zohar J. Cross-cutting issues and future directions for the OCD spectrum. Psychiatry Research. 170: 3-6. PMID 19811839 DOI: 10.1016/J.Psychres.2008.07.015  0.534
2009 Stein DJ, Denys D, Gloster AT, Hollander E, Leckman JF, Rauch SL, Phillips KA. Obsessive-compulsive disorder: diagnostic and treatment issues. The Psychiatric Clinics of North America. 32: 665-85. PMID 19716996 DOI: 10.1016/J.Psc.2009.05.007  0.546
2009 King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Archives of General Psychiatry. 66: 583-90. PMID 19487623 DOI: 10.1001/Archgenpsychiatry.2009.30  0.389
2009 Smith CJ, Lang CM, Kryzak L, Reichenberg A, Hollander E, Silverman JM. Familial associations of intense preoccupations, an empirical factor of the restricted, repetitive behaviors and interests domain of autism. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 50: 982-90. PMID 19298470 DOI: 10.1111/J.1469-7610.2009.02060.X  0.34
2008 Hollander E, Abramowitz JS, Koran LM, Pallanti S. Obsessive-compulsive disorder: Strategies for optimal treatment Journal of Clinical Psychiatry. 69: 1647-1657. PMID 19192448 DOI: 10.4088/Jcp.V69N1015  0.449
2008 Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, Zohar J, Hollander E, Kasper S, Möller HJ, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 9: 248-312. PMID 18949648 DOI: 10.1080/15622970802465807  0.693
2008 Cai G, Edelmann L, Goldsmith JE, Cohen N, Nakamine A, Reichert JG, Hoffman EJ, Zurawiecki DM, Silverman JM, Hollander E, Soorya L, Anagnostou E, Betancur C, Buxbaum JD. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. Bmc Medical Genomics. 1: 50. PMID 18925931 DOI: 10.1186/1755-8794-1-50  0.32
2008 Pallanti S, Hollander E. Obsessive-compulsive disorder spectrum as a scientific "metaphor". Cns Spectrums. 13: 6-15. PMID 18849906 DOI: 10.1017/S1092852900026882  0.522
2008 Hollander E. New insights into bipolar disorder. Cns Spectrums. 13: 743. PMID 18849891 DOI: 10.1017/S1092852900013833  0.479
2008 Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology. 58: 37-47. PMID 18781089 DOI: 10.1159/000154478  0.34
2008 Soorya L, Kiarashi J, Hollander E. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 17: 753-71, viii. PMID 18775368 DOI: 10.1016/J.Chc.2008.06.003  0.41
2008 Berlin HA, Hamilton H, Hollander E. Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments. The Mount Sinai Journal of Medicine, New York. 75: 174-203. PMID 18704978 DOI: 10.1002/Msj.20045  0.501
2008 Hollander E. New developments in autism spectrum disorders. Interview by Dr. George Lundberg. Medscape Journal of Medicine. 10: 152. PMID 18679531  0.367
2008 Bartz JA, Hollander E. Oxytocin and experimental therapeutics in autism spectrum disorders Progress in Brain Research. 170: 451-462. PMID 18655901 DOI: 10.1016/S0079-6123(08)00435-4  0.681
2008 Hollander E. Differential treatment response, neuroinflammation, and psychosis associated with chromosome deletion. Cns Spectrums. 13: 459-60. PMID 18567970 DOI: 10.1017/S1092852900016679  0.37
2008 Hollander E. Trauma, multiple sclerosis, delayed sleep phase disorder, subjective experiences, and duration of illness in GAD. Cns Spectrums. 13: 361-2. PMID 18496473 DOI: 10.1017/S1092852900016497  0.379
2008 Parikh MS, Kolevzon A, Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. Journal of Child and Adolescent Psychopharmacology. 18: 157-78. PMID 18439113 DOI: 10.1089/Cap.2007.0041  0.355
2008 Hollander E, Braun A, Simeon D. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depression and Anxiety. 25: 317-29. PMID 18412058 DOI: 10.1002/da.20500  0.42
2008 Hollander E. Brain stimulation, alternative medicine, and impulsivity and compulsivity. Cns Spectrums. 13: 271-2. PMID 18408644 DOI: 10.1017/S1092852900016357  0.435
2008 Trivedi MH, Hollander E, Nutt D, Blier P. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression Journal of Clinical Psychiatry. 69: 246-258. PMID 18363453 DOI: 10.4088/Jcp.V69N0211  0.337
2008 Pallanti S, Masetti S, Bernardi S, Innocenti A, Markella M, Hollander E. Obsessive compulsive disorder comorbidity in DBA. Clinical Practice and Epidemiology in Mental Health : Cp & Emh. 4: 6. PMID 18331650 DOI: 10.1186/1745-0179-4-6  0.441
2008 Dell'Osso B, Allen A, Altamura AC, Buoli M, Hollander E. Impulsive-compulsive buying disorder: clinical overview. The Australian and New Zealand Journal of Psychiatry. 42: 259-66. PMID 18330768 DOI: 10.1080/00048670701881561  0.478
2008 Phillips KA, Hollander E. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image. 5: 13-27. PMID 18325859 DOI: 10.1016/J.Bodyim.2007.12.003  0.412
2008 Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. The Journal of Clinical Psychiatry. 69: 452-6. PMID 18312057 DOI: 10.4088/Jcp.V69N0316  0.358
2008 Allen A, Hadley SJ, Kaplan A, Simeon D, Friedberg J, Priday L, Baker BR, Greenberg JL, Hollander E. An open-label trial of venlafaxine in body dysmorphic disorder. Cns Spectrums. 13: 138-44. PMID 18227745 DOI: 10.1017/S1092852900016291  0.405
2008 Hollander E. Obsessive-compulsive spectrum phenomena and the DSM-V developmental process. Cns Spectrums. 13: 107-8. PMID 18227740 DOI: 10.1017/S1092852900016229  0.311
2008 Hollander E. Happy New 2008: from mild cognitive impairment to pleasure circuitry. Cns Spectrums. 13: 17-8. PMID 18204408 DOI: 10.1017/S1092852900016084  0.372
2008 Díaz-Marsá M, Carrasco JL, Basurte E, Sáiz J, López-Ibor JJ, Hollander E. Enhanced cortisol suppression in eating disorders with impulsive personality features. Psychiatry Research. 158: 93-7. PMID 18182170 DOI: 10.1016/J.Psychres.2007.06.020  0.482
2008 Hollander E, Bartz J, Berlin H, Allen A, Buchsbaum M, Braun A, Simeon D. S.06.01 The obsessive-compulsive spectrum disorders European Neuropsychopharmacology. 18: S165. DOI: 10.1016/S0924-977X(08)70141-X  0.738
2008 Bartz JA, Young LJ, Hollander E, Buxbaum JD, Ring RH. Preclinical animal models of autistic spectrum disorders (ASD) Animal and Translational Models For Cns Drug Discovery. 1: 353-394. DOI: 10.1016/B978-0-12-373861-5.00011-4  0.697
2008 Evers M, Hollander E. Excitotoxicity in Autism Autism. 133-145. DOI: 10.1007/978-1-60327-489-0_6  0.484
2007 Buxbaum JD, Cai G, Nygren G, Chaste P, Delorme R, Goldsmith J, RÃ¥stam M, Silverman JM, Hollander E, Gillberg C, Leboyer M, Betancur C. Mutation analysis of the NSD1 gene in patients with autism spectrum disorders and macrocephaly. Bmc Medical Genetics. 8: 68. PMID 18001468 DOI: 10.1186/1471-2350-8-68  0.361
2007 Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder. The American Journal of Psychiatry. 164: 5-53. PMID 17849776  0.361
2007 Simeon D, Baker B, Chaplin W, Braun A, Hollander E. An open-label trial of divalproex extended-release in the treatment of borderline personality disorder. Cns Spectrums. 12: 439-43. PMID 17545954 DOI: 10.1017/S1092852900015315  0.393
2007 Josephson SC, Hollander E, Sumner J. Comprehensive treatment of three patients with comorbid OCPD and ADHD Cns Spectrums. 12: 338-342. PMID 17514078 DOI: 10.1017/S1092852900021131  0.447
2007 Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsäter H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 144: 484-91. PMID 17427195 DOI: 10.1002/Ajmg.B.30493  0.316
2007 Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent JB, Skaug JL, Thompson AP, Senman L, Feuk L, Qian C, Bryson SE, Jones MB, ... ... Hollander E, et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics. 39: 319-28. PMID 17322880 DOI: 10.1038/Ng1985  0.314
2007 Dell'Osso B, Altamura AC, Mundo E, Marazziti D, Hollander E. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. International Journal of Clinical Practice. 61: 98-104. PMID 17229184 DOI: 10.1111/J.1742-1241.2006.01167.X  0.539
2007 Simeon D, Knutelska M, Smith L, Baker BR, Hollander E. A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation. Psychiatry Research. 149: 177-84. PMID 17169436 DOI: 10.1016/J.Psychres.2005.11.014  0.317
2007 Mick TM, Hollander E. Impulsive-compulsive sexual behavior. Cns Spectrums. 11: 944-55. PMID 17146408 DOI: 10.1017/S1092852900015133  0.48
2007 Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S. Oxytocin increases retention of social cognition in autism. Biological Psychiatry. 61: 498-503. PMID 16904652 DOI: 10.1016/J.Biopsych.2006.05.030  0.675
2007 Hollander E, Sood E, Pallanti S, Baldini-Rossi N, Baker B. Pharmacological treatments of pathological gambling. Journal of Gambling Studies. 21: 99-110. PMID 15789195 DOI: 10.1007/s10899-004-1932-8  0.322
2007 Hollander E. New Uses for Old Drugs and New Circuits for Old Disorders Cns Spectrums. 12: 799-800. DOI: 10.1017/S1092852900015509  0.353
2007 Hollander E, Kim S, Khanna S, Pallanti S. Obsessive-Compulsive Disorder and Obsessive-Compulsive Spectrum Disorders: Diagnostic and Dimensional Issues Cns Spectrums. 12: 5-13. DOI: 10.1017/S1092852900002467  0.538
2007 Zohar J, Westenberg H, Stein D, Hollander E. The Cape Town consensus statement regarding the diagnosis and treatment of obsessive-compulsive disorder European Psychiatry. 22: S295. DOI: 10.1016/J.Eurpsy.2007.01.999  0.567
2006 Pallanti S, Bernardi S, Quercioli L, DeCaria C, Hollander E. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. Cns Spectrums. 11: 956-64. PMID 17146409 DOI: 10.1017/S1092852900015145  0.342
2006 Hollander E, Wasserman S, Swanson EN, Chaplin W, Schapiro ML, Zagursky K, Novotny S. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology. 16: 541-8. PMID 17069543 DOI: 10.1089/Cap.2006.16.541  0.395
2006 Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. International Clinical Psychopharmacology. 21: 363-7. PMID 17012983 DOI: 10.1097/01.Yic.0000224787.13782.0F  0.327
2006 Hollander E, Allen A. Is compulsive buying a real disorder, and is it really compulsive? The American Journal of Psychiatry. 163: 1670-2. PMID 17012670 DOI: 10.1176/Ajp.2006.163.10.1670  0.504
2006 Dell'Osso B, Altamura AC, Allen A, Marazziti D, Hollander E. Epidemiologic and clinical updates on impulse control disorders: a critical review. European Archives of Psychiatry and Clinical Neuroscience. 256: 464-75. PMID 16960655 DOI: 10.1007/S00406-006-0668-0  0.468
2006 Bartz JA, Hollander E. The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior. Hormones and Behavior. 50: 518-28. PMID 16884725 DOI: 10.1016/J.Yhbeh.2006.06.018  0.71
2006 Anagnostou E, Esposito K, Soorya L, Chaplin W, Wasserman S, Hollander E. Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. Journal of Clinical Psychopharmacology. 26: 444-6. PMID 16855475 DOI: 10.1097/01.Jcp.0000227703.72117.Bc  0.489
2006 Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. The American Journal of Psychiatry. 163: 1252-63. PMID 16816232 DOI: 10.1176/Appi.Ajp.163.7.1252  0.378
2006 Dell'Osso B, Nestadt G, Allen A, Hollander E. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review. The Journal of Clinical Psychiatry. 67: 600-10. PMID 16669725 DOI: 10.4088/Jcp.V67N0411  0.433
2006 Kolevzon A, Mathewson KA, Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. The Journal of Clinical Psychiatry. 67: 407-14. PMID 16649827 DOI: 10.4088/Jcp.V67N0311  0.49
2006 Hollander E, Dell'Osso B. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder. International Clinical Psychopharmacology. 21: 189-91. PMID 16528143 DOI: 10.1097/01.Yic.0000199453.54799.Cc  0.401
2006 Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30: 338-352. PMID 16455175 DOI: 10.1016/J.Pnpbp.2005.11.003  0.762
2006 Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. The American Journal of Psychiatry. 163: 303-12. PMID 16449486 DOI: 10.1176/Appi.Ajp.163.2.303  0.322
2006 Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D, Katsovich L, Scahill L, King RA, Woody SR, Tolin D, Hollander E, Kano Y, Leckman JF. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Molecular Psychiatry. 11: 495-504. PMID 16432526 DOI: 10.1038/Sj.Mp.4001798  0.345
2006 Hollander E, Kaplan A, Schmeidler J, Yang H, Li D, Koran LM, Barbato LM. Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 472-7. PMID 16387985 DOI: 10.1176/Jnp.17.4.472  0.453
2006 Dell'Osso B, Altamura AC, Allen A, Hollander E. Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions. Cns Spectrums. 10: 966-79, 983. PMID 16344833 DOI: 10.1017/S1092852900010531  0.386
2006 Hollander E, Soorya L, Wasserman S, Esposito K, Chaplin W, Anagnostou E. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 209-13. PMID 16316486 DOI: 10.1017/S1461145705005791  0.501
2006 Dell'Osso B, Allen A, Hollander E. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder. Expert Opinion On Pharmacotherapy. 6: 2727-40. PMID 16316311 DOI: 10.1517/14656566.6.15.2727  0.41
2006 Hollander E. Obsessive-compulsive Disorder Psychiatric Annals. 36. DOI: 10.3928/00485713-20060701-06  0.517
2006 Hollander E, Alterman R, Dell’Osso B. Approaching Treatment-Resistant Obsessive-compulsive Disorder With Brain Stimulation Interventions: The State of the Art Psychiatric Annals. 36. DOI: 10.3928/00485713-20060701-01  0.366
2006 Hollander E. Acting on Impulse: What's New About Impulse Control Disorders and Why Would We Consider Them Forms of Behavioral Addiction? Cns Spectrums. 11: 903-904. DOI: 10.1017/S1092852900015066  0.431
2006 Dell' Osso B, Altamura A, Hadley S, Baker B, Hollander E. An open-label trial of escitalopram in the treatment of impulsive-compulsive internet usage disorder European Neuropsychopharmacology. 16: S82-S83. DOI: 10.1016/S0924-977X(06)80097-0  0.454
2006 Hollander E. C.16.01 Anxiety spectrum disorders over life cycle European Neuropsychopharmacology. 16: S585-S586. DOI: 10.1016/S0924-977X(06)70856-2  0.306
2005 Dell'Osso B, Allen A, Hollander E. Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review. Clinical Practice and Epidemiology in Mental Health : Cp & Emh. 1: 21. PMID 16216125 DOI: 10.1186/1745-0179-1-21  0.509
2005 Dell'Osso B, Hollander E. The impact of comorbidity on the management of pathological gambling. Cns Spectrums. 10: 619-21. PMID 16041292 DOI: 10.1017/S109285290001957X  0.517
2005 Hollander E, Anagnostou E, Chaplin W, Esposito K, Haznedar MM, Licalzi E, Wasserman S, Soorya L, Buchsbaum M. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biological Psychiatry. 58: 226-32. PMID 15939406 DOI: 10.1016/J.Biopsych.2005.03.040  0.359
2005 Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. The American Journal of Psychiatry. 162: 621-4. PMID 15741486 DOI: 10.1176/Appi.Ajp.162.3.621  0.484
2005 Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? The American Journal of Psychiatry. 162: 137-45. PMID 15625212 DOI: 10.1176/appi.ajp.162.1.137  0.394
2005 Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, Iyengar R. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 582-9. PMID 15602505 DOI: 10.1038/Sj.Npp.1300627  0.346
2005 Hollander E, Zohar J. Beyond refractory obsessions and anxiety states: toward remission. The Journal of Clinical Psychiatry. 3-5. PMID 15554781  0.441
2005 Ketter TA, Ginsberg DL, Akiskal HS, Keck PE, Weisler RH, Hirschfeld RM, Hollander E. Reassessing Carbamazepine in the Treatment of Bipolar Disorder Clinical Implications of New Data Cns Spectrums. 10: 1-2. DOI: 10.1017/S1092852900023063  0.388
2005 Liebowitz MR, Ninan PT, Schneier FR, Blanco C, Ginsberg DL, Hollander E. Integrating Neurobiology and Psychopathology into Evidence-Based Treatment of Social Anxiety Disorder Cns Spectrums. 10: 1-2. DOI: 10.1017/S1092852900010336  0.647
2005 Costa P, Samuels J, Bagby M, Daffin L, Norton H, Gabbard GO, Rothenberg A, Shapiro D, Serpell L, Hirani V, Hollander E, Sharma L, Hand I, Fricke S, Nestadt G, et al. Obsessive-Compulsive Personality Disorder: A Review Personality Disorders. 405-477. DOI: 10.1002/0470090383.ch6  0.371
2004 Novotny S, Hollander E, Phillips A, Allen A, Wasserman S, Iyengar R. Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 7: 249-54. PMID 15132762 DOI: 10.1017/S146114570400433X  0.467
2004 Kaplan A, Hollander E. Comorbidity in compulsive hoarding: a case report. Cns Spectrums. 9: 71-3. PMID 14999178 DOI: 10.1017/S1092852900008385  0.5
2004 Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A, Swinson RP. WCA recommendations for the long-term treatment of panic disorder. Cns Spectrums. 8: 17-30. PMID 14767395 DOI: 10.1017/S109285290000691X  0.514
2004 Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, Okasha A, Swinson RP, Zohar J. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. Cns Spectrums. 8: 7-16. PMID 14767394 DOI: 10.1017/S1092852900006908  0.432
2004 Simeon D, Nelson D, Elias R, Greenberg J, Hollander E. Relationship of personality to dissociation and childhood trauma in borderline personality disorder. Cns Spectrums. 8: 755-62. PMID 14712173 DOI: 10.1017/S109285290001912X  0.392
2004 Pallanti S, Quercioli L, Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of disability. The American Journal of Psychiatry. 161: 53-8. PMID 14702250 DOI: 10.1176/Appi.Ajp.161.1.53  0.34
2004 Buxbaum JD, Silverman J, Keddache M, Smith CJ, Hollander E, Ramoz N, Reichert JG. Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Molecular Psychiatry. 9: 144-50. PMID 14699429 DOI: 10.1038/Sj.Mp.4001465  0.308
2004 Hollander E, Allen A, Steiner M, Wheadon DE, Oakes R, Burnham DB. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine. The Journal of Clinical Psychiatry. 64: 1113-21. PMID 14628989 DOI: 10.4088/Jcp.V64N0919  0.408
2004 Allen A, Hollander E. Similarities and Differences Between Body Dysmorphic Disorder and Other Disorders Psychiatric Annals. 34: 927-933. DOI: 10.3928/0048-5713-20041201-15  0.495
2004 Hollander E, Bartz J. A 48-year-old Man With a History of Obsessive-compulsive Disorder, Comorbid Bipolar, Panic Disorders Psychiatric Annals. 31: 808-810. DOI: 10.3928/0048-5713-20041101-04  0.741
2004 Kaplan A, Hollander E. A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder Focus. 2: 454-461. DOI: 10.1176/FOC.2.3.454  0.385
2004 Hollander E. Introduction: The Impact and Management of the Bipolar Spectrum in 2004 Cns Spectrums. 9: 5-5. DOI: 10.1017/S1092852900028832  0.506
2004 Hollander E, Robinson R, Compton D. New Developments in Autism Clinical Trials Cns Spectrums. 9: 20-21. DOI: 10.1017/S1092852900008324  0.36
2004 Hollander E. Mood and Anxiety Disorders: Special Considerations in Women Cns Spectrums. 9: 4-4. DOI: 10.1017/S1092852900002315  0.432
2003 Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP. WCA recommendations for the long-term treatment of generalized anxiety disorder. Cns Spectrums. 8: 53-61. PMID 14767398 DOI: 10.1017/S1092852900006945  0.498
2003 Van Ameringen M, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP. WCA recommendations for the long-term treatment of social phobia. Cns Spectrums. 8: 40-52. PMID 14767397 DOI: 10.1017/S1092852900006933  0.506
2003 Stein DJ, Bandelow B, Hollander E, Nutt DJ, Okasha A, Pollack MH, Swinson RP, Zohar J. WCA Recommendations for the long-term treatment of posttraumatic stress disorder. Cns Spectrums. 8: 31-9. PMID 14767396 DOI: 10.1017/S1092852900006921  0.487
2003 Hollander E, Phillips AT, Yeh CC. Targeted treatments for symptom domains in child and adolescent autism. Lancet (London, England). 362: 732-4. PMID 12957098 DOI: 10.1016/S0140-6736(03)14236-5  0.362
2003 Kaplan A, Hollander E. A review of pharmacologic treatments for obsessive-compulsive disorder. Psychiatric Services (Washington, D.C.). 54: 1111-8. PMID 12883138 DOI: 10.1176/Appi.Ps.54.8.1111  0.501
2003 Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 64: 640-7. PMID 12823077 DOI: 10.4088/Jcp.V64N0604  0.382
2003 Hollander E, Friedberg J, Wasserman S, Allen A, Birnbaum M, Koran LM. Venlafaxine in treatment-resistant obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 64: 546-50. PMID 12755657 DOI: 10.4088/Jcp.V64N0508  0.46
2003 Hollander E, Tracy KA, Swann AC, Coccaro EF, McElroy SL, Wozniak P, Sommerville KW, Nemeroff CB. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1186-97. PMID 12700713 DOI: 10.1038/Sj.Npp.1300153  0.459
2003 Sood ED, Pallanti S, Hollander E. Diagnosis and treatment of pathologic gambling. Current Psychiatry Reports. 5: 9-15. PMID 12685996 DOI: 10.1007/S11920-003-0003-7  0.46
2003 Hollander E, Kahn J. Review: in obsessive-compulsive disorder, clomipramine may be more effective than selective serotonin reuptake inhibitors after controlling for other factors. Evidence-Based Mental Health. 6: 23. PMID 12588829 DOI: 10.1136/Ebmh.6.1.23  0.423
2003 Hollander E, Kaplan A, Stahl SM. A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 4: 30-4. PMID 12582975 DOI: 10.3109/15622970309167908  0.463
2003 Hollander E, King A, Delaney K, Smith CJ, Silverman JM. Obsessive-compulsive behaviors in parents of multiplex autism families. Psychiatry Research. 117: 11-6. PMID 12581816 DOI: 10.1016/S0165-1781(02)00304-9  0.361
2003 Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 3: 171-99. PMID 12516310 DOI: 10.3109/15622970209150621  0.389
2003 Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 193-8. PMID 12496956 DOI: 10.1038/Sj.Npp.1300021  0.448
2003 Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J. Treatment non-response in OCD: methodological issues and operational definitions. The International Journal of Neuropsychopharmacology. 5: 181-91. PMID 12135542 DOI: 10.1017/S1461145702002900  0.458
2003 Hollander E, Samons DM. Efficacy of paroxetine for relapse prevention in social anxiety disorder Current Psychiatry Reports. 5: 249-249. DOI: 10.1007/S11920-003-0052-Y  0.446
2002 Pallanti S, Baldini Rossi N, Sood E, Hollander E. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. The Journal of Clinical Psychiatry. 63: 1034-9. PMID 12444818 DOI: 10.4088/JCP.v63n1114  0.321
2002 Hadley SJ, Greenberg J, Hollander E. Diagnosis and treatment of body dysmorphic disorder in adolescents. Current Psychiatry Reports. 4: 108-13. PMID 11914171 DOI: 10.1007/S11920-002-0043-4  0.341
2002 Silverman JM, Smith CJ, Schmeidler J, Hollander E, Lawlor BA, Fitzgerald M, Buxbaum JD, Delaney K, Galvin P. Symptom domains in autism and related conditions: evidence for familiality. American Journal of Medical Genetics. 114: 64-73. PMID 11840508 DOI: 10.1002/Ajmg.10048  0.317
2002 Mathew SJ, Coplan JD, Perko KA, Goetz RR, de la Neuz M, Hollander E, Liebowitz MR, Fallon BA. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder. Depression and Anxiety. 14: 199-208. PMID 11754126 DOI: 10.1002/Da.1067  0.33
2001 Simeon D, Guralnik O, Knutelska M, Hollander E, Schmeidler J. Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder Neuropsychopharmacology. 25: 793-795. PMID 11682263 DOI: 10.1016/S0893-133X(01)00288-3  0.42
2001 Hollander E, Dolgoff-Kaspar R, Cartwright C, Rawitt R, Novotny S. An open trial of divalproex sodium in autism spectrum disorders. The Journal of Clinical Psychiatry. 62: 530-4. PMID 11488363 DOI: 10.4088/Jcp.V62N07A05  0.456
2001 Buchsbaum MS, Hollander E, Haznedar MM, Tang C, Spiegel-Cohen J, Wei TC, Solimando A, Buchsbaum BR, Robins D, Bienstock C, Cartwright C, Mosovich S. Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 4: 119-25. PMID 11466160 DOI: 10.1017/S1461145701002280  0.389
2001 Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. The Journal of Clinical Psychiatry. 62: 199-203. PMID 11305707 DOI: 10.4088/Jcp.V62N0311  0.556
2001 Vythilingum B, Cartwright C, Hollander E. Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors. International Clinical Psychopharmacology. S7-13. PMID 11110014 DOI: 10.1097/00004850-200008002-00003  0.408
2001 Mathew SJ, Coplan JD, Perko KA, Goetz RR, Neuz Mdl, Hollander E, Liebowitz MR, Fallon BA. Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive–compulsive disorder Presented in part at the 2000 APA meeting May, Chicago, Illinois, Young Investigators Poster, and the 2001 ADAA Conference in Atlanta, Georgia Depression and Anxiety. 14: 199. DOI: 10.1002/Da.1067.Abs  0.42
2000 Haznedar MM, Buchsbaum MS, Wei TC, Hof PR, Cartwright C, Bienstock CA, Hollander E. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. The American Journal of Psychiatry. 157: 1994-2001. PMID 11097966 DOI: 10.1176/Appi.Ajp.157.12.1994  0.4
2000 Simeon D, Guralnik O, Hazlett EA, Spiegel-Cohen J, Hollander E, Buchsbaum MS. Feeling unreal: a PET study of depersonalization disorder. The American Journal of Psychiatry. 157: 1782-8. PMID 11058475 DOI: 10.1176/Appi.Ajp.157.11.1782  0.401
2000 Hollander E, Kaplan A, Allen A, Cartwright C. Pharmacotherapy for obsessive-compulsive disorder. The Psychiatric Clinics of North America. 23: 643-56. PMID 10986733 DOI: 10.1016/S0193-953X(05)70186-6  0.389
2000 Hollander E, Buchalter AJ, DeCaria CM. Pathological gambling. The Psychiatric Clinics of North America. 23: 629-42. PMID 10986732 DOI: 10.1016/s0193-953x(05)70185-4  0.365
2000 Marazziti D, Masala I, Rossi A, Hollander E, Presta S, Giannaccini G, Mazzoni MR, Dell'Osso L, Lucacchini A, Cassano GB. Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD. Neuropsychobiology. 41: 171-7. PMID 10828725 DOI: 10.1159/000026656  0.302
2000 Novotny S, Hollander E, Allen A, Mosovich S, Aronowitz B, Cartwright C, DeCaria C, Dolgoff-Kaspar R. Increased growth hormone response to sumatriptan challenge in adult autistic disorders. Psychiatry Research. 94: 173-7. PMID 10808042 DOI: 10.1016/S0165-1781(00)00134-7  0.363
2000 Carrasco JL, Díaz-Marsá M, Hollander E, César J, Saiz-Ruiz J. Decreased platelet monoamine oxidase activity in female bulimia nervosa. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 10: 113-7. PMID 10706992 DOI: 10.1016/S0924-977X(99)00061-9  0.363
2000 Hollander E, Kaplan A, Cartwright C, Reichman D. Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report. Journal of Child Neurology. 15: 132-5. PMID 10695900 DOI: 10.1177/088307380001500214  0.466
2000 Stein DJ, Hollander E, Simeon D, Cohen L. Impulsivity scores in patients with obsessive-compulsive disorder. The Journal of Nervous and Mental Disease. 182: 240-1. PMID 10678323 DOI: 10.1097/00005053-199404000-00009  0.51
2000 Hollander E, Novotny S, Allen A, Aronowitz B, Cartwright C, DeCaria C. The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 163-7. PMID 10649829 DOI: 10.1016/S0893-133X(99)00121-9  0.399
2000 Diaz-Marsa M, Carrasco JL, Hollander E, Cesar J, Saiz-Ruiz J. Decreased platelet monoamine oxidase activity in female anorexia nervosa Acta Psychiatrica Scandinavica. 101: 226-230. DOI: 10.1034/J.1600-0447.2000.101003226.X  0.387
2000 Stein DJ, Allen A, Bobes J, Eisen JL, Figuera ML, Iikura Y, Koran LM, Hollander E. Quality of Life in Obsessive-Compulsive Disorder Cns Spectrums. 5: 37-39. DOI: 10.1017/S1092852900025025  0.517
2000 Hollander E, Zohar J, Marazziti D. The Fourth IOCDC Cns Spectrums. 5: 4-4. DOI: 10.1017/S1092852900024950  0.379
2000 Hollander E. Exploring the Boundaries of Anxiety and Psychosis Cns Spectrums. 5: 17-17. DOI: 10.1017/S1092852900021581  0.491
2000 Hollander E, Twersky R. Body dysmorphic disorder: assessment and treatment with serotonergic drugs European Neuropsychopharmacology. 10: 125-126. DOI: 10.1016/S0924-977X(00)80022-X  0.413
2000 Novotny S, Hollander E, Allen A, Aronowitz B, DeCaria C, Cartwright C, Yaffe R. 523. Behavioral response to oxytocin challenge in adult autistic disorders Biological Psychiatry. 47: S159. DOI: 10.1016/S0006-3223(00)00793-9  0.423
1999 Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, Simeon D. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Archives of General Psychiatry. 56: 1033-9. PMID 10565503 DOI: 10.1001/Archpsyc.56.11.1033  0.494
1999 Hollander E, DelGiudice-Asch G, Simon L, Schmeidler J, Cartwright C, DeCaria CM, Kwon J, Cunningham-Rundles C, Chapman F, Zabriskie JB. B lymphocyte antigen D8/17 and repetitive behaviors in autism. The American Journal of Psychiatry. 156: 317-20. PMID 9989573 DOI: 10.1176/Ajp.156.2.317  0.315
1999 Cartwright C, Hollander E. SSRIs in the treatment of obsessive-compulsive disorder. Depression and Anxiety. 105-13. PMID 9809222 DOI: 10.1002/(Sici)1520-6394(1998)8:1+<105::Aid-Da16>3.0.Co;2-T  0.439
1999 Rauch SL, Benkelfat C, Dager SR, Greenberg BD, Hendler T, Hollander E, Laruelle M, Rosenberg DR, Saxena S, Zohar J, Baxter L.R. J. Neuroimaging research and neurocircuitry models of obsessive-compulsive disorder: Proceedings of the Third IOCDC Cns Spectrums. 4: 25-34. DOI: 10.1017/S1092852900007392  0.455
1999 Hollander E, Rosen J. OC Spectrum Disorders: The Impulsive and Schizo-Obsessive Clusters Cns Spectrums. 4: 16-21. DOI: 10.1017/S1092852900007379  0.413
1999 Hollander E. The Neuroscience of the Tourette Syndrome Spectrum Cns Spectrums. 4: 13-13. DOI: 10.1017/S1092852900000754  0.362
1998 Simeon D, Guralnik O, Gross S, Stein DJ, Schmeidler J, Hollander E. The detection and measurement of depersonalization disorder. The Journal of Nervous and Mental Disease. 186: 536-42. PMID 9741559 DOI: 10.1097/00005053-199809000-00004  0.533
1998 Simeon D, Stein DJ, Hollander E. Treatment of depersonalization disorder with clomipramine. Biological Psychiatry. 44: 302-3. PMID 9715363 DOI: 10.1016/S0006-3223(98)00023-7  0.533
1998 Hollander E, Kwon J, Weiller F, Cohen L, Stein DJ, DeCaria C, Liebowitz M, Simeon D. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects. Psychiatry Research. 79: 213-7. PMID 9704868 DOI: 10.1016/S0165-1781(98)00041-9  0.46
1998 Simeon D, Stein DJ, Gross S, Islam N, Schmeidler J, Hollander E. A double-blind trial of fluoxetine in pathologic skin picking. The Journal of Clinical Psychiatry. 58: 341-7. PMID 9515971 DOI: 10.4088/Jcp.V58N0802  0.361
1998 Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRIs British Journal of Psychiatry. 173: 7-12. DOI: 10.1192/S0007125000297845  0.521
1998 Hollander E, Greenwald S, Neville D, Johnson J, Hornig CD, Weissman MM. Uncomplicated and Comorbid Obsessive-Compulsive Disorder in an Epidemiologic Sample Cns Spectrums. 3: 10-18. DOI: 10.1017/S1092852900007148  0.422
1998 Hollander E. New Neural Constructs for Obsessive-Compulsive Disorder Cns Spectrums. 3: 17-17. DOI: 10.1017/S1092852900006106  0.456
1998 Hollander E, Begaz T, DeCaria CM. Pharmacologic Approaches in the Treatment of Pathological Gambling Cns Spectrums. 3: 72-80. DOI: 10.1017/S1092852900006039  0.476
1998 DeCaria CM, Begaz T, Hollander E. Serotonergic and Noradrenergic Function in Pathological Gambling Cns Spectrums. 3: 38-47. DOI: 10.1017/S1092852900006003  0.423
1998 Hollander E, Cartwright C, Wong CM, Decaria CM, Delgiudice-Asch G, Buchsbaum MS, Aronowitz BR. A dimensional approach to the autism spectrum Cns Spectrums. 3: 22-39. DOI: 10.1017/S1092852900005678  0.41
1998 Hollander E, Delgiudice-Asch G, Cartwright C, DeCaria C, Bienstock C. Auto-immune findings in OCD spectrum disorders and their implications for treatment European Neuropsychopharmacology. 8: S125. DOI: 10.1016/S0924-977X(98)80112-0  0.46
1998 Hollander E, DeCaria C, Cartwright C. OCD spectrum disorders — From impulsivity to compulsivity European Psychiatry. 13: 196S-196S. DOI: 10.1016/S0924-9338(99)80232-6  0.513
1998 Hollander E, Aronowitz B, DeCaria C, Wong C, Cartwright C, DelGuidice-Asch G. 10. Neurobiology and treatment of autism Biological Psychiatry. 43. DOI: 10.1016/S0006-3223(98)90458-9  0.328
1997 Simeon D, Gross S, Guralnik O, Stein DJ, Schmeidler J, Hollander E. Feeling unreal: 30 cases of DSM-III-R depersonalization disorder. The American Journal of Psychiatry. 154: 1107-13. PMID 9247397 DOI: 10.1176/Ajp.154.8.1107  0.549
1997 Hollander E, Greenwald S, Neville D, Johnson J, Hornig CD, Weissman MM. Uncomplicated and comorbid obsessive-compulsive disorder in an epidemiologic sample. Depression and Anxiety. 4: 111-9. PMID 9166639 DOI: 10.1017/S1092852900007148  0.422
1997 Grossman R, Cohen L, Rosen J, DeCaria C, Hollander E. Seasonal effects in prolactin response to m-chlorophenylpiperazine challenge in obsessive-compulsive disorder. Biological Psychiatry. 39: 982-5. PMID 9162213 DOI: 10.1016/0006-3223(95)00658-3  0.324
1997 Grove G, Coplan JD, Hollander E. The neuroanatomy of 5-HT dysregulation and panic disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 9: 198-207. PMID 9144099 DOI: 10.1176/Jnp.9.2.198  0.458
1997 Stein DJ, Trestman RL, Mitropoulou V, Coccaro EF, Hollander E, Siever LJ. Impulsivity and serotonergic function in compulsive personality disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 8: 393-8. PMID 9116474 DOI: 10.1176/Jnp.8.4.393  0.579
1997 Josephson SC, Hollander E. Body dysmorphic disorder by proxy Journal of Clinical Psychiatry. 58: 86-87. PMID 9062380 DOI: 10.4088/Jcp.V58N0206C  0.456
1997 Simeon D, Cohen LJ, Stein DJ, Schmeidler J, Spadaccini E, Hollander E. Comorbid self-injurious behaviors in 71 female hair-pullers: a survey study. The Journal of Nervous and Mental Disease. 185: 117-9. PMID 9048705 DOI: 10.1097/00005053-199702000-00009  0.358
1997 Stein DJ, Hollander E, DeCaria CM, Simeon D, Cohen L, Aronowitz B. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures. Biological Psychiatry. 40: 508-13. PMID 8879471 DOI: 10.1016/0006-3223(95)00470-X  0.484
1997 HOLLANDER E, BENZAQUEN SD. The obsessive-compulsive spectrum disorders International Review of Psychiatry. 9: 99-110. DOI: 10.1080/09540269775628  0.535
1997 Cohen LJ, Stein D, Galynker I, Hollander E. Towards an integration of psychological and biological models of obsessive-compulsive disorder: Phylogenetic considerations Cns Spectrums. 2: 26-44. DOI: 10.1017/S109285290001107X  0.505
1997 Hollander E, Stein DJ, Kwon JH, Rowland C, Wong CM, Broatch J, Himelein C. Psychosocial Function and Economic Costs of Obsessive-Compulsive Disorder Cns Spectrums. 2: 16-25. DOI: 10.1017/S1092852900011068  0.49
1997 Delgiudice-Asch G, Hollander E. Altered Immune Function In Autism Cns Spectrums. 2: 61-68. DOI: 10.1017/S1092852900004909  0.346
1997 Aronowitz BR, Decaria C, Allen A, Weiss N, Saunders A, Margolin L, Mosovich S, Baum M, Hollander E. The Neuropsychiatry of Autism and Asperger's Disorder: Review of the Literature and Case Reports Cns Spectrums. 2: 43-60. DOI: 10.1017/S1092852900004892  0.445
1997 Wong CM, Hollander E. Serotonin Function and Gender Effects in Migraine Production and OCD Cns Spectrums. 2: 25-27. DOI: 10.1017/S1092852900001760  0.403
1997 Hollander E, Wong C, DeCaria C, Aronowitz B, Margolin L. Is biological psychiatry addressing the treatment of eating disorders, OCD and OCD spectrum disorders? Biological Psychiatry. 42: 264S. DOI: 10.1016/S0006-3223(97)88029-8  0.524
1996 Wong CM, Hollander E. Headache response to m-chlorophenylpiperazine in obsessive-compulsive disorder and normal controls Biological Psychiatry. 40: 544-546. PMID 8879476 DOI: 10.1016/0006-3223(96)00164-3  0.44
1996 Cohen LJ, Hollander E, DeCaria CM, Stein DJ, Simeon D, Liebowitz MR, Aronowitz BR. Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjects. The Journal of Neuropsychiatry and Clinical Neurosciences. 8: 82-5. PMID 8845706 DOI: 10.1176/Jnp.8.1.82  0.657
1996 Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. Journal of Clinical Psychopharmacology. 16: 121-9. PMID 8690827 DOI: 10.1097/00004714-199604000-00004  0.381
1996 Milrod B, Busch FN, Hollander E, Aronson A, Siever L. A 23-year-old woman with panic disorder treated with psychodynamic psychotherapy. The American Journal of Psychiatry. 153: 698-703. PMID 8615418 DOI: 10.1176/Ajp.153.5.698  0.303
1996 Grossman R, Hollander E. Treatment of obsessive-compulsive disorder with venlafaxine. The American Journal of Psychiatry. 153: 576-7. PMID 8599411 DOI: 10.1176/Ajp.153.4.576B  0.51
1996 Simeon D, Hollander E, Stein DJ, DeCaria C, Cohen LJ, Saoud JB, Islam N, Hwang M. Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine. Psychiatry Research. 58: 161-4. PMID 8570768 DOI: 10.1016/0165-1781(95)02538-8  0.545
1996 Hollander E, Prohovnik I, Stein DJ. Increased cerebral blood flow during m-CPP exacerbation of obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 7: 485-90. PMID 8555752 DOI: 10.1176/Jnp.7.4.485  0.433
1996 Hollander E, Grossman R, Stein DJ, Kwon J. Borderline Personality Disorder and Impulsive-Aggression: The Role for Divalproex Sodium Treatment Psychiatric Annals. 26: S464-S469. DOI: 10.3928/0048-5713-19960702-11  0.558
1996 Hollander E. Obsessive-compulsive disorder related disorders International Clinical Psychopharmacology. 11: 75-88. DOI: 10.1097/00004850-199612005-00007  0.536
1996 Wong CM, Hollander E. New Dimensions in the OCD Spectrum: Autism, Pathologic Gambling, and Compulsive Buying Cns Spectrums. 1: 44-53. DOI: 10.1017/S1092852900002649  0.509
1996 Josephson SC, Hollander E, Fallon B, Stein DJ. Obsessive-Compulsive Disorder, Body Dysmorphic Disorder, and Hypochondriasis: Three Variations on a Theme Cns Spectrums. 1: 24-31. DOI: 10.1017/S1092852900002613  0.606
1996 Grove G, Coplan J, Margolin L, Hollander E. The Neuroanatomy of Serotonin (5-HT) Dysregulation in Obsessive-Compulsive Disorder Cns Spectrums. 1: 16-22. DOI: 10.1017/S1092852900002595  0.357
1996 Hollander E, Benzaquen SD. Is There a Distinct OCD Spectrum? Cns Spectrums. 1: 17-26. DOI: 10.1017/S1092852900000651  0.532
1996 Hollander E, Cherkasky S, Wong C, Grossman R, DeCaria C, Aronowitz B. Maintenance treatment for obsessive-compulsive disorder Biological Psychiatry. 39: 610. DOI: 10.1016/0006-3223(96)84318-6  0.508
1995 Skodol AE, Oldham JM, Hyler SE, Stein DJ, Hollander E, Gallaher PE, Lopez AE. Patterns of anxiety and personality disorder comorbidity Journal of Psychiatric Research. 29: 361-374. PMID 8748061 DOI: 10.1016/0022-3956(95)00015-W  0.595
1995 Foa EB, Kozak MJ, Goodman WK, Hollander E, Jenike MA, Rasmussen SA. DSM-IV field trial: obsessive-compulsive disorder. The American Journal of Psychiatry. 152: 90-6. PMID 7802127 DOI: 10.1176/Ajp.152.1.90  0.394
1995 Stein DJ, Hollander E, Cohen L, Simeon D, Aronowitz B. Serotonergic responsivity in trichotillomania: neuroendrocrine effects of m-chlorophenylpiperazine. Biological Psychiatry. 37: 414-6. PMID 7772651 DOI: 10.1016/0006-3223(94)00199-D  0.344
1995 Stein DJ, Simeon D, Cohen LJ, Hollander E. Trichotillomania and obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 28-34; discussion 35. PMID 7713862 DOI: 10.1176/Ajp.150.7.1131-A  0.607
1995 Simeon D, Hollander E, Stein DJ, Cohen L, Aronowitz B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. The American Journal of Psychiatry. 152: 1207-9. PMID 7625473 DOI: 10.1176/Ajp.152.8.1207  0.587
1995 Stein DJ, Spadaccini E, Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. International Clinical Psychopharmacology. 10: 11-8. PMID 7622800 DOI: 10.1097/00004850-199503000-00002  0.472
1995 Hadigan CM, Walsh BT, Buttinger C, Hollander E. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa. Biological Psychiatry. 37: 504-11. PMID 7619973 DOI: 10.1016/0006-3223(94)00169-4  0.385
1995 Stein DJ, Mullen L, Islam MN, Cohen L, DeCaria CM, Hollander E. Compulsive and impulsive symptomatology in trichotillomania. Psychopathology. 28: 208-13. PMID 7480576 DOI: 10.1159/000284923  0.594
1995 Koran LM, McElroy SL, Davidson JRT, Rasmussen SA, Hollander E, Jenike MA. P-6-9 Double-blind comparison of fluvoxamine and clomipramine in obsessive compulsive disorder in the United States European Neuropsychopharmacology. 5: 371. DOI: 10.1016/0924-977X(95)90658-Z  0.419
1995 Stein DJ, Trestman R, Coccaro E, Mitropoulou V, Hollander E, Siever L. Serotonergic responsivity in compulsive personality disorder Biological Psychiatry. 37: 645. DOI: 10.1016/0006-3223(95)94598-Q  0.594
1994 Hollander E, Stein DJ, DeCaria CM, Cohen L, Saoud JB, Skodol AE, Kellman D, Rosnick L, Oldham JM. Serotonergic sensitivity in borderline personality disorder: preliminary findings. The American Journal of Psychiatry. 151: 277-80. PMID 8296905 DOI: 10.1176/Ajp.151.2.277  0.526
1994 Stein DJ, Hollander E, Chan S, DeCaria CM, Hilal S, Liebowitz MR, Klein DF. Computed tomography and neurological soft signs in obsessive-compulsive disorder. Psychiatry Research. 50: 143-50. PMID 8272450 DOI: 10.1016/0925-4927(93)90026-E  0.416
1994 Stein DJ, Hollander E, Cohen L, Frenkel M, Saoud JB, DeCaria C, Aronowitz B, Levin A, Liebowitz MR, Cohen L. Neuropsychiatric impairment in impulsive personality disorders. Psychiatry Research. 48: 257-66. PMID 8272447 DOI: 10.1016/0165-1781(93)90076-S  0.461
1994 Stein DJ, Keating J, Zar HJ, Hollander E. A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences. 6: 23-9. PMID 8148633 DOI: 10.1176/Jnp.6.1.23  0.444
1994 Stein DJ, Hollander E, Simeon D, Cohen L, Islam MN, Aronowitz B. Neurological soft signs in female trichotillomania patients, obsessive-compulsive disorder patients, and healthy control subjects. The Journal of Neuropsychiatry and Clinical Neurosciences. 6: 184-7. PMID 8044043 DOI: 10.1176/Jnp.6.2.184  0.496
1994 Hollander E, De Caria C, Stein D, Simeon D, Cohen L, Hwang M, Islam M. Behavioral response to m-CPP. Biological Psychiatry. 35: 426-7. PMID 8018791 DOI: 10.1016/0006-3223(94)90011-6  0.354
1994 Stein DJ, Dodman NH, Borchelt P, Hollander E. Behavioral disorders in veterinary practice: relevance to psychiatry. Comprehensive Psychiatry. 35: 275-85. PMID 7956183 DOI: 10.1016/0010-440X(94)90019-1  0.535
1994 Aronowitz B, Liebowitz M, Hollander E, Fazzini E, Durlach-Misteli C, Frenkel M, Mosovich S, Garfinkel R, Saoud J, DelBene D, Cohen L, Jaeger A, Rubin AL. Neuropsychiatric and neuropsychological findings in conduct disorder and attention-deficit hyperactivity disorder Journal of Neuropsychiatry and Clinical Neurosciences. 6: 245-249. PMID 7950346 DOI: 10.1176/JNP.6.3.245  0.483
1994 Carrasco JL, Sáiz-Ruiz J, Hollander E, César J, López-Ibor JJ. Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatrica Scandinavica. 90: 427-31. PMID 7892775 DOI: 10.1111/J.1600-0447.1994.Tb01619.X  0.328
1994 Towey JP, Tenke CE, Bruder GE, Leite P, Friedman D, Liebowitz M, Hollander E. Brain event-related potential correlates of overfocused attention in obsessive-compulsive disorder Psychophysiology. 31: 535-543. PMID 7846214 DOI: 10.1111/J.1469-8986.1994.Tb02346.X  0.58
1994 Stein DJ, Patterson R, Hollander E. Expert Systems for Psychiatric Pharmacotherapy Psychiatric Annals. 24: 37-41. DOI: 10.3928/0048-5713-19940101-12  0.391
1994 Stein DJ, Hollander E. Sexual Dysfunction Associated with the Drug Treatment of Psychiatric Disorders Cns Drugs. 2: 78-86. DOI: 10.2165/00023210-199402010-00006  0.396
1994 Cohen L, Hollander E, Stein D, Simeon D, Spadaccini E, Islam N, Aronowitz B. Demographic and clinical profile of 110 hairpullers Biological Psychiatry. 35: 698. DOI: 10.1016/0006-3223(94)90955-5  0.342
1994 Stein D, Hollander E, Cohen L, Simeon D, Aronowitz B. Serotonergic responsivity in trichotillomania Biological Psychiatry. 35: 645. DOI: 10.1016/0006-3223(94)90766-8  0.502
1994 Stein D, Hollander E, DeCaria C, Simeon D, Cohen L. Serotonergic responsivity in borderline personality disorder Biological Psychiatry. 35: 644. DOI: 10.1016/0006-3223(94)90765-X  0.553
1994 Aronowitz B, Hollander E, DeCaria C, Cohen L, Stein D, Simeon D. Neuropsychology of OCD: Preliminary findings Biological Psychiatry. 35: 638. DOI: 10.1016/0006-3223(94)90742-0  0.467
1993 Prichep LS, Mas F, Hollander E, Liebowitz M, John ER, Almas M, DeCaria CM, Levine RH. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Research. 50: 25-32. PMID 8511221 DOI: 10.1016/0925-4927(93)90021-9  0.561
1993 Hollander E, Hwang MY, Mullen LS, DeCaria C, Stein DJ, Cohen L. Clinical and research issues in depersonalization syndrome. Psychosomatics. 34: 193-4. PMID 8456168 DOI: 10.1016/S0033-3182(93)71919-2  0.353
1993 Stein DJ, Hutt CS, Spitz JL, Hollander E. Compulsive picking and obsessive-compulsive disorder. Psychosomatics. 34: 177-81. PMID 8456163 DOI: 10.1016/S0033-3182(93)71911-8  0.594
1993 Hollander E, Cohen L, Richards M, Mullen L, DeCaria C, Stern Y. A pilot study of the neuropsychology of obsessive-compulsive disorder and Parkinson's disease: basal ganglia disorders. The Journal of Neuropsychiatry and Clinical Neurosciences. 5: 104-7. PMID 8428130 DOI: 10.1176/Jnp.5.1.104  0.425
1993 Hollander E, Stein DJ, DeCaria CM, Saoud JB, Klein DF, Liebowitz MR. A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder. Biological Psychiatry. 33: 747-9. PMID 8353170 DOI: 10.1016/0006-3223(93)90126-X  0.574
1993 Hollander E, Cohen LJ, DeCaria C, Saoud JB, Stein DJ, Cooper TB, Islam NN, Liebowitz MR, Klein DF. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD. Biological Psychiatry. 34: 407-13. PMID 8218609 DOI: 10.1016/0006-3223(93)90186-H  0.359
1993 Papp LA, Klein DF, Martinez J, Schneier F, Cole R, Liebowitz MR, Hollander E, Fyer AJ, Jordan F, Gorman JM. Diagnostic and substance specificity of carbon-dioxide-induced panic. The American Journal of Psychiatry. 150: 250-7. PMID 8123056 DOI: 10.1176/Ajp.150.2.250  0.522
1993 Hwang MY, Martin AM, Lindenmayer JP, Stein D, Hollander E. Treatment of schizophrenia with obsessive-compulsive features with serotonin reuptake inhibitors. The American Journal of Psychiatry. 150: 1127. PMID 8100402 DOI: 10.1176/Ajp.150.7.1127  0.385
1993 Stein DJ, Hollander E, Liebowitz MR. Neurobiology of impulsivity and the impulse control disorders. The Journal of Neuropsychiatry and Clinical Neurosciences. 5: 9-17. PMID 7679020 DOI: 10.1176/Jnp.5.1.9  0.694
1993 Hollander E, Stein DJ, Saoud JB, DeCaria CM, Cooper TB, Islam MN, Liebowitz MR, Stanley M. Effects of fenfluramine on plasma homovanillic acid in healthy subjects. Journal of Neural Transmission. General Section. 90: 81-4. PMID 1466879 DOI: 10.1007/Bf01250520  0.53
1993 Hwang MY, Hollander E. Schizo-Obsessive Disorders Psychiatric Annals. 23: 396-401. DOI: 10.3928/0048-5713-19930701-11  0.515
1993 Stein DJ, Hollander E. Impulsive Aggression and Obsessive-Compulsive Disorder Psychiatric Annals. 23: 389-395. DOI: 10.3928/0048-5713-19930701-10  0.594
1993 Hollander E. Obsessive-Compulsive Spectrum Disorders: An Overview Psychiatric Annals. 23: 355-358. DOI: 10.3928/0048-5713-19930701-05  0.511
1993 Stein DJ, Hollander E, Skodol AE. Anxiety Disorders and Personality Disorders: A Review Journal of Personality Disorders. 7: 87-104. DOI: 10.1521/Pedi.1993.7.2.87  0.581
1993 FALLON BA, LIEBOWITZ MR, SALM??N E, SCHNEIER FR, JUSINO C, HOLLANDER E, KLEIN DF. Fluoxetine for Hypochondriacal Patients Without Major Depression Journal of Clinical Psychopharmacology. 13: 438???441. DOI: 10.1097/00004714-199312000-00010  0.538
1993 SCHNEIER FR, SAOUD JB, CAMPEAS R, FALLON BA, HOLLANDER E, COPLAN J, LIEBOWITZ MR. Buspirone in Social Phobia Journal of Clinical Psychopharmacology. 13: 251???256. DOI: 10.1097/00004714-199308000-00004  0.568
1993 SCHNEIER FR, CARRASCO JL, HOLLANDER E, CAMPEAS R, FALLON B, SAOUD JB, FEERICK J, LIEBOWITZ MR. Alpidem in the Treatment of Panic Disorder Journal of Clinical Psychopharmacology. 13: 150???153. DOI: 10.1097/00004714-199304000-00011  0.651
1993 Hollander E, DeCaria C, Stein D, Simeon D, Hwang M, Cohen L. Preferential response of serotonergic medications in OCD related disorders European Neuropsychopharmacology. 3: 291-293. DOI: 10.1016/0924-977X(93)90079-2  0.596
1992 Hollander E, DeCaria CM, Aronowitz B, Klein DF, Liebowitz MR, Shaffer D. A pilot follow-up study of childhood soft signs and the development of adult psychopathology. The Journal of Neuropsychiatry and Clinical Neurosciences. 3: 186-9. PMID 1821234 DOI: 10.1176/Jnp.3.2.186  0.639
1992 Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Archives of General Psychiatry. 49: 21-8. PMID 1728249 DOI: 10.1001/Archpsyc.1992.01820010021003  0.588
1992 Stein DJ, Shoulberg N, Helton K, Hollander E. The neuroethological approach to obsessive-compulsive disorder. Comprehensive Psychiatry. 33: 274-81. PMID 1643870 DOI: 10.1016/0010-440X(92)90053-S  0.519
1992 Hollander E, Stein DJ, Saoud JB, DeCaria CM, Cooper TB, Trungold S, Stanley M, Liebowitz MR. Effects of fenfluramine on plasma HVA in OCD. Psychiatry Research. 42: 185-8. PMID 1631253 DOI: 10.1016/0165-1781(92)90081-D  0.527
1992 Fallon BA, Campeas R, Schneier FR, Hollander E, Feerick J, Hatterer J, Goetz D, Davies S, Liebowitz MR. Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 4: 70-5. PMID 1627966 DOI: 10.1176/JNP.4.1.70  0.556
1992 Marazziti D, Hollander E, Lensi P, Ravagli S, Cassano GB. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder. Psychiatry Research. 42: 41-51. PMID 1603880 DOI: 10.1016/0165-1781(92)90037-4  0.328
1992 Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R. Phenelzine vs atenolol in social phobia. A placebo-controlled comparison. Archives of General Psychiatry. 49: 290-300. PMID 1558463 DOI: 10.1001/Archpsyc.49.4.290  0.519
1992 Hollander E, Neville D, Frenkel M, Josephson S, Liebowitz MR. Body dysmorphic disorder. Diagnostic issues and related disorders. Psychosomatics. 33: 156-65. PMID 1557480 DOI: 10.1016/S0033-3182(92)71991-4  0.652
1992 Stein DJ, Hollander E. Dermatology and conditions related to obsessive-compulsive disorder. Journal of the American Academy of Dermatology. 26: 237-42. PMID 1552059 DOI: 10.1016/0190-9622(92)70033-C  0.604
1992 Schneier FR, Chin SJ, Hollander E, Liebowitz MR. Fluoxetine in social phobia. Journal of Clinical Psychopharmacology. 12: 62-4. PMID 1552041 DOI: 10.1097/00001573-199202000-00020  0.407
1992 Hollander E, Carrasco JL, Mullen LS, Trungold S, DeCaria CM, Towey J. Left hemispheric activation in depersonalization disorder: a case report. Biological Psychiatry. 31: 1157-62. PMID 1525279 DOI: 10.1016/0006-3223(92)90161-R  0.499
1992 Hollander E, Stein DJ, Decaria CM, Cohen L, Islam M, Frenkel M. Disorders related to OCD--neurobiology. Clinical Neuropharmacology. 259A-260A. PMID 1498832 DOI: 10.1097/00002826-199201001-00135  0.583
1992 Hollander E, Cohen L, DeCaria C, Stein DJ, Trungold-Apter S, Islam M. Fluoxetine and depersonalization syndrome. Psychosomatics. 33: 361-2. PMID 1410214 DOI: 10.1016/S0033-3182(92)71984-7  0.343
1992 SCHNEIER FR, CHIN SJ, HOLLANDER E, LIEBOWITZ MR. Fluoxetine in Social Phobia Journal of Clinical Psychopharmacology. 12: 62???63. DOI: 10.1097/00004714-199202000-00018  0.407
1992 Stein DJ, Hollander E, Mullen LS, Decaria CM, Liebowitz MR. Comparison of clomipramine, alprazolam and placebo in the treatment of obsessive?compulsive disorder Human Psychopharmacology: Clinical and Experimental. 7: 389-395. DOI: 10.1002/Hup.470070604  0.641
1991 Hollander E, DeCaria C, Gully R, Nitescu A, Suckow RF, Gorman JM, Klein DF, Liebowitz MR. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Research. 36: 1-17. PMID 2017519 DOI: 10.1016/0165-1781(91)90113-4  0.604
1991 Hollander E, DeCaria C, Nitescu A, Cooper T, Stover B, Gully R, Klein DF, Liebowitz MR. Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Research. 37: 161-77. PMID 1876628 DOI: 10.1016/0165-1781(91)90073-X  0.599
1991 STEIN DJ, FRENKEL M, HOLLANDER E. Classification of Koro American Journal of Psychiatry. 148: 1279-a-1280. DOI: 10.1176/Ajp.148.9.1279-A  0.319
1991 Hollander E. Neurologic Soft Signs in Obsessive-Compulsive Disorder-Reply Archives of General Psychiatry. 48: 278. DOI: 10.1001/Archpsyc.1991.01810270090014  0.407
1990 Hatterer JA, Gorman JM, Fyer AJ, Campeas RB, Schneier FR, Hollander E, Papp LA, Liebowitz MR. Pharmacotherapy of four men with paruresis. The American Journal of Psychiatry. 147: 109-11. PMID 2403470 DOI: 10.1176/Ajp.147.1.109  0.481
1990 Towey J, Bruder G, Hollander E, Friedman D, Erhan H, Liebowitz M, Sutton S. Endogenous event-related potentials in obsessive-compulsive disorder Biological Psychiatry. 28: 92-98. PMID 2378924 DOI: 10.1016/0006-3223(90)90626-D  0.546
1990 Hollander E, Liebowitz MR, DeCaria C, Klein DF. Fenfluramine, cortisol, and anxiety. Psychiatry Research. 31: 211-3. PMID 2360951 DOI: 10.1016/0165-1781(90)90124-N  0.533
1990 Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF. Fluoxetine in panic disorder. Journal of Clinical Psychopharmacology. 10: 119-21. PMID 2341585 DOI: 10.1097/00004714-199004000-00007  0.628
1990 Liebowitz MR, Hollander E, Fairbanks J, Campeas R. Fluoxetine for adolescents with obsessive-compulsive disorder. The American Journal of Psychiatry. 147: 370-1. PMID 2309962 DOI: 10.1176/Ajp.147.3.370B  0.601
1990 Hollander E, Schiffman E, Cohen B, Rivera-Stein MA, Rosen W, Gorman JM, Fyer AJ, Papp L, Liebowitz MR. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Archives of General Psychiatry. 47: 27-32. PMID 2294853 DOI: 10.1001/Archpsyc.1990.01810130029005  0.605
1990 Liebowitz MR, Hollander E, Schneier F, Campeas R, Welkowitz L, Hatterer J, Fallon B. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders. Acta Psychiatrica Scandinavica. Supplementum. 360: 29-34. PMID 2248064 DOI: 10.1111/J.1600-0447.1990.Tb05321.X  0.66
1990 Hollander E, Neville D, DeCaria C, Mullen L, Schneier FR, Liebowitz MR. On dysmorphophobia misdiagnosed as obsessive-compulsive disorder. Psychosomatics. 31: 468-9. PMID 2247582 DOI: 10.1016/S0033-3182(90)72157-3  0.621
1990 Liebowitz MR, Hollander E, Schneier F, Campeas R, Fallon B, Welkowitz L, Cloitre M, Davies S. Anxiety and depression: discrete diagnostic entities? Journal of Clinical Psychopharmacology. 10: 61S-66S. PMID 2198302 DOI: 10.1097/00004714-199006001-00012  0.592
1990 Gorman JM, Papp LA, Martinez J, Goetz RR, Hollander E, Liebowitz MR, Jordan F. High-dose carbon dioxide challenge test in anxiety disorder patients. Biological Psychiatry. 28: 743-757. PMID 2124151 DOI: 10.1016/0006-3223(90)90510-9  0.457
1990 HOLLANDER E, LIEBOWITZ MR, DECARIA C, FAIRBANKS J, FALLON B, KLEIN DF. Treatment of Depersonalization with Serotonin Journal of Clinical Psychopharmacology. 10: 200???202. DOI: 10.1097/00004714-199006000-00008  0.674
1989 Hollander E, Papp L, Campeas R, DeCaria C, Liebowitz MR. More on self mutilation and obsessive compulsive disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 33: 675. PMID 3058294 DOI: 10.1177/070674378803300728  0.609
1989 Liebowitz MR, Hollander E. Lactate-induced anxiety. Biological Psychiatry. 25: 669-70. PMID 2923929 DOI: 10.1016/0006-3223(89)90235-7  0.52
1989 Hollander E, Liebowitz MR, Gorman JM, Cohen B, Fyer A, Klein DF. Cortisol and sodium lactate-induced panic. Archives of General Psychiatry. 46: 135-40. PMID 2913972 DOI: 10.1001/Archpsyc.1989.01810020037007  0.593
1989 Goetz RR, Gorman JM, Dillon DJ, Papp LA, Hollander E, Fyer AJ, Liebowitz MR, Klein DF. Do panic disorder patients indiscriminately endorse somatic complaints Psychiatry Research-Neuroimaging. 29: 207-213. PMID 2798599 DOI: 10.1016/0165-1781(89)90035-8  0.403
1989 Hollander E, Fairbanks J, Decaria C, Liebowitz MR. Pharmacological dissection of panic and depersonalization. The American Journal of Psychiatry. 146: 402. PMID 2784040 DOI: 10.1176/Ajp.146.3.402  0.55
1989 Hollander E, Liebowitz MR, Cohen B, Gorman JM, Fyer AJ, Papp LA, Klein DF. Prolactin and sodium lactate-induced panic. Psychiatry Research. 28: 181-91. PMID 2748770 DOI: 10.1016/0165-1781(89)90046-2  0.572
1989 Hollander E, Liebowitz MR, Winchel R, Klumker A, Klein DF. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. The American Journal of Psychiatry. 146: 768-70. PMID 2658627 DOI: 10.1176/Ajp.146.6.768  0.65
1989 Papp LA, Goetz R, Cole R, Klein DF, Jordan F, Liebowitz MR, Fyer AJ, Hollander E, Gorman JM. Hypersensitivity to carbon dioxide in panic disorder. The American Journal of Psychiatry. 146: 779-81. PMID 2499198 DOI: 10.1176/AJP.146.6.779  0.468
1989 Hollander E, De Caria C, Liebowitz MR. Biological Aspects of Obsessive Compulsive Disorder Psychiatric Annals. 19: 80-87. DOI: 10.3928/0048-5713-19890201-08  0.66
1989 HOLLANDER E, FAIRBANKS J, DECARIA C, LIEBOWITZ MR. Dr. Hollander and Associates Reply American Journal of Psychiatry. 146: 1361-1361. DOI: 10.1176/Ajp.146.10.1361  0.436
1989 LIEBOWITZ MR, HOLLANDER E, SCHNEIER F, CAMPEAS R, HATTERER J, PAPP L, FAIRBANKS J, SANDBERG D, DAVIES S, STEIN M. BRIEF REPORTS Journal of Clinical Psychopharmacology. 9: 423???427. DOI: 10.1097/00004714-198912000-00007  0.605
1989 Hollander E, DeCaria C, Fay M, Liebowitz MR. Repeat M-CPP challenge during fluoxetine treatment in obsessive-compulsive disorder: Behavioral and neuroendocrine responses Biological Psychiatry. 25: A8. DOI: 10.1016/0006-3223(89)91501-1  0.618
1989 Hollander E, DeCaria C, Cooper T, Liebowitz MR. Neuroendocrine sensitivity in obsessive-compulsive disorder Biological Psychiatry. 25: A5. DOI: 10.1016/0006-3223(89)91496-0  0.651
1988 Liebowitz MR, Campeas R, Levin A, Sandberg D, Hollander E, Papp L. Pharmacotherapy of social phobia. A condition distinct from panic attacks. Psychosomatics. 28: 305-8. PMID 3324159 DOI: 10.1016/S0033-3182(87)72520-1  0.491
1988 Hollander E, Liebowitz MR. Augmentation of antiobsessional treatment with fenfluramine. The American Journal of Psychiatry. 145: 1314-5. PMID 3138920 DOI: 10.1176/Ajp.145.10.1314A  0.48
1988 Liebowitz MR, Fyer AJ, Gorman JM, Campeas RB, Sandberg DP, Hollander E, Papp LA, Klein DF. Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. Journal of Psychiatric Research. 7-31. PMID 3050060 DOI: 10.1016/0022-3956(88)90067-2  0.646
1988 Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. The American Journal of Psychiatry. 145: 1015-7. PMID 2839998 DOI: 10.1176/Ajp.145.8.1015  0.669
1988 HOLLANDER E, FAY M, LIEBOWITZ MR. Clonidine and Clomipramine in Obsessive-Compulsive Disorder American Journal of Psychiatry. 145: 388-a-389. DOI: 10.1176/Ajp.145.3.388-A  0.664
1988 FYER AJ, LIEBOWITZ MR, GORMAN JM, CAMPEAS R, LEVIN A, SANDBERG D, FYER M, HOLLANDER E, PAPP L, GOETZ D, KLEIN DF. Effects of Clonidine on Alprazolam Discontinuation in Panic Patients Journal of Clinical Psychopharmacology. 8: 270???274. DOI: 10.1097/00004714-198808000-00006  0.55
1988 Hollander E. Neuropharmacology and neuropsychiatry of obsessive-compulsive disorder Journal of Psychiatric Research. 22: 317-318. DOI: 10.1016/0022-3956(88)90055-6  0.517
1987 Liebowitz MR, Campeas R, Hollander E. MAOIs: impact on social behavior. Psychiatry Research. 22: 89-90. PMID 3659222 DOI: 10.1016/0165-1781(87)90054-0  0.477
Show low-probability matches.